Skip to main content

Main menu

  • Home
  • Current Issue
  • Ahead of Print
  • Past Issues
  • Info for
    • Authors
    • Print Subscriptions
  • About
    • About the Journal
    • About the Academy
    • Editorial Board
  • Feedback
  • Alerts
  • AAPL

User menu

  • Alerts

Search

  • Advanced search
Journal of the American Academy of Psychiatry and the Law
  • AAPL
  • Alerts
Journal of the American Academy of Psychiatry and the Law

Advanced Search

  • Home
  • Current Issue
  • Ahead of Print
  • Past Issues
  • Info for
    • Authors
    • Print Subscriptions
  • About
    • About the Journal
    • About the Academy
    • Editorial Board
  • Feedback
  • Alerts
Research ArticlePractice Resource

Practice Resource for Reproductive Psychiatry/Women’s Mental Health in Forensic Psychiatry Practice

Susan Hatters Friedman, Renée Sorrentino, Aimee Kaempf, Marilyn Price, Jacqueline Landess, Anna Glezer, Joseph Penn, Patricia Westmoreland, Catherine Lewis, Cathleen Cerny and Jeffrey Janofsky
Journal of the American Academy of Psychiatry and the Law Online December 2024, 52 (4 Supplement) S1-S31; DOI: https://doi.org/10.29158/JAAPL.240103-24
Susan Hatters Friedman
MD, MSt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Renée Sorrentino
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aimee Kaempf
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marilyn Price
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacqueline Landess
MD, JD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Glezer
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Penn
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia Westmoreland
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Lewis
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cathleen Cerny
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey Janofsky
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

Abstract

This practice resource seeks to describe salient problems within reproductive psychiatry (also known as women’s mental health) for the practice of forensic psychiatry. Understanding is critical and can help combat gender bias in such evaluations. Forensic psychiatric evaluations in the criminal realm, including evaluations related to neonaticide, infanticide, filicide, child abuse, and kidnapping by cesarean, require an understanding of reproductive psychiatry. Civil forensic evaluations requiring knowledge about reproductive psychiatry include parenting evaluations and risk assessments in the postpartum. Similarly, forensic psychiatrists performing a treatment role within corrections or forensic hospitals recognize the importance of understanding mental illness in pregnancy and postpartum, lactation, mother-baby units, and forced separation or custody loss. In addition to menstruation, pregnancy, and postpartum, specific concerns that bear consideration within reproductive forensic psychiatry include the periods of girlhood and menstruation. Finally, eating disorders and substance misuse bear additional attention in this group.

  • practice resource
  • pregnancy
  • postpartum
  • menopause
  • corrections
  • forensic hospitals

The American Academy of Psychiatry and the Law’s Practice Resource for Prescribing in Corrections describes the challenges of prescribing medications for mental health disorders to persons in jails and prisons.1 Friedman et al.2 provided further recommendations concerning these guidelines, focusing on the unique challenges of prescribing for women in corrections through the lifecycle. The following practice resource expands upon this by reviewing forensic concerns particularly relevant to the female population and reproductive matters.

Women are more likely than men to be diagnosed with anxiety and depression. Similarly, exposure to traumatic events, poverty, discrimination, and unequal responsibilities for caring for children and elderly family members is more common in women.2,3 In correctional settings, women have higher rates of psychiatric symptoms compared with men in correctional facilities and compared with women living in the community.2 They also have higher rates of comorbidities.4 Friedman et al.2 outline the prevalence and treatment of depression, anxiety disorders, bipolar disorder, psychotic disorders, trauma and stress-related disorders, substance use disorders, and sleep disorders in women in the correctional system.

Women involved in the criminal justice system have significant mental and physical health symptoms in addition to socioeconomic disparities and physical vulnerabilities when compared with women without criminal justice involvement. Common characteristics of justice-involved women include unmarried status, age ranging from late twenties to early thirties, and having at least two children.5 The majority of these mothers have been the primary caregiver for their children prior to incarceration.4 Compared with justice-involved males, justice-involved women are more likely to report a history of victimization.6 This victimization, including sexual abuse, tends to occur in childhood.7

Forensic evaluators need to recognize these gender-based differences to identify women’s treatment and risk management needs appropriately.2 Understanding whether gender-based differences are based on research or the product of bias is also important in formulating forensic opinions.8

Review of Mental Illness and Pregnancy

Epidemiology and Course of Mental Illness in Pregnancy

Depression and anxiety are particularly common in pregnancy but often overlooked and underdiagnosed. Several theories explain why this is the case. The first is that depression is more common in women over their lifetime and it often onsets during the reproductive years. Secondly, pregnancy itself is a stressful event from a physiological and hormonal perspective as well as psychosocially. It can, therefore, trigger illness in someone who has a vulnerability to depression because of biological, genetic, environmental, or other reasons.

It is essential to recognize perinatal depression because it can have significant negative outcomes on the pregnancy for both mother and baby, including increased risks of preeclampsia, small gestational age (SGA), preterm deliveries, substance use, neurodevelopmental issues in infant, higher rates of neonatal intensive care unit (NICU) stays, and more. A number of risk factors predispose to depression in pregnancy, including prior history, unplanned pregnancy or ambivalence, lack of social support, partner conflict or intimate partner violence (IPV), and medical complications.9,10 Discontinuation of psychiatric medication, often abruptly upon learning of the pregnancy, increases the risk of experiencing a return of symptoms in pregnancy.2 It is often hard to diagnose depression in pregnancy because many of the symptoms that clinicians use to diagnose depression (changes in sleep, appetite, and energy) are typical changes in pregnancy itself. Anxiety disorders are also common in pregnancy. Rates in the literature vary depending on the criteria used for the diagnosis, ranging from five to 40 percent for generalized anxiety disorder, two percent for panic disorder, or 15 to 40 percent for obsessive-compulsive disorder (OCD).11

Bipolar disorder, impacting about two percent of the population, often begins during the reproductive years of women and can significantly impact pregnancy outcomes. One of the most common triggers for a mood episode in bipolar disorder is sleep disturbance, and 80 percent of pregnant women describe some form of impaired sleep. Women with bipolar disorder may have worse pregnancy outcomes, including babies with smaller head circumferences and more medical complications during pregnancy unrelated to medication treatment.12

Psychotic disorders can worsen during pregnancy, impact reproductive outcomes, and lead to postpartum challenges. It is challenging to study pregnancy outcomes in women with schizophrenia, as outcomes can often be attributed to many factors, from the illness itself to the treatments to co-occurring behaviors, such as smoking.13

Women with mental illnesses often have a recurrence of psychiatric symptoms during pregnancy, and often, this is related to a discontinuation of the medication. Medications used to manage all psychiatric disorders in pregnancy require a careful risk-benefit analysis, given the risks of untreated mental illness.2

Miscarriage and Abortion and Their Relationship to Mental Health

Miscarriage, spontaneous pregnancy loss, may have psychological sequelae related to both the grief aspects of the loss as well as the contribution of the hormonal changes because of the loss of pregnancy. There is an increased risk of depression after a pregnancy loss,14 and it is important to monitor women closely after both early and late pregnancy losses. Some studies suggest the rates of depression are as high as 15 to 20 percent after such an event.15,16 The risk of attempted suicide also increases in this population.17

Abortion, or elective termination, has been studied extensively to determine whether there are psychological consequences. Abortion does not increase the risks of suicide or negative psychological outcomes, according to studies from the United States, such as the Turnaway Study18 or database studies from other countries, such as Denmark.19 Women seeking a termination may be more vulnerable and may need additional support. There was also evidence that women denied access to abortion experience increased risk of depression and an overall poor mental health outcomes.18

Pseudocyesis and Delusional Pregnancy

The term “pseudocyesis” comes from the Greek terms meaning false and pregnancy.20 The woman is noted to have signs and symptoms of pregnancy, except there is no fetus. These symptoms may include abdominal distention, enlarged breasts, cessation of menses, morning sickness, and weight gain. Pseudocyesis may be categorized as a somatoform disorder.20 Although antipsychotic agents play an important role in treating delusions of pregnancy, among patients with pseudocyesis, psychotherapy plays an equally important role.20

There is a blurry line of demarcation between pseudocyesis and delusional pregnancy, both rare syndromes in developed countries.21 Psychological antecedents noted include ambivalence about pregnancy, loss, and relationship problems. Seeman21 noted these delusions often occur in the context of both pressure to conceive and fears of pregnancy. Delusional pregnancy may be a singular delusion or may occur with other delusions, part of DeClerambault’s syndrome (erotomania) or Capgras syndrome (delusional misidentification).21 Delusions may appear in the context of symptoms that cause abdominal distention or endocrine disturbances, such as hypothyroidism. When these psychotic symptoms are treated with antipsychotic medication, high prolactin levels may lead to amenorrhea and galactorrhea.21 Antipsychotic agents are also often associated with weight gain and thus increased abdominal size. These side effects could, in turn, reinforce the woman’s belief that she was pregnant.

Denial and Concealment of Pregnancy

Miller22 described the denial of pregnancy as having three subtypes: pervasive denial, affective denial, and psychotic denial. Pervasive denial refers to cases in which the existence of the pregnancy is kept from the woman’s awareness. Women may not experience the usual changes of pregnancy, such as weight gain, cessation of menses, and breast changes, and may even misinterpret active labor. A European study found the rate of pervasive denial of pregnancy to be one out of every 2,455 deliveries.23 In contrast, in affective denial, although women are intellectually aware of their pregnancy, they do not make much emotional or physical preparation. Rather, they “continue to think, feel, and behave as though they were not pregnant” (Ref. 22, p 83). For example, some women with substance use disorders may defend against guilty feelings associated with their substance use during pregnancy in this manner. Finally, psychotic denial of pregnancy occurs in some women with psychosis (and potentially a history of custody loss of other children). Psychotic denial of pregnancy may be intermittent.

Women may continue to experience menstruation-like bleeding and may rationalize the symptoms of pregnancy as having other causes. Friedman and colleagues noted, “Physicians should consider the possibility of denial or concealment of pregnancy in young women presenting with complaints of nausea, weight gain, and abdominal symptoms, with or without amenorrhea” (Ref. 24, p 121).

In contrast, concealment of pregnancy is purposeful. The woman is aware that she is pregnant and actively conceals her pregnancy from others. She may do so because of her plans for abortion or adoption, or she may fear the reaction to her pregnancy by her family, friends, or coworkers. Concealment of pregnancy may occur after some period of denial of pregnancy when the woman can no longer deny it to herself.

An Ohio study of hospital deliveries of women with denial or concealment of pregnancy24 noted that some women had a pervasive denial of pregnancy until delivery, whereas others had a persistent denial of pregnancy until the third trimester. At that time, they did acknowledge their pregnancy but did not obtain prenatal care. Among those with affective denial, some were ambivalent, whereas others planned adoption, and still others planned abortions or reported they had been raped. Friedman and colleagues24 found that women with denial or concealment of pregnancy were predominantly multigravida and were adults who were students or who were employed. Fewer than half reported that the father of the baby was supportive. Mothers who had either denied or concealed their pregnancies until birth were frequently discharged home with their newborns.

Criminal Forensic Psychiatry

Gender Bias in Forensic Evaluations and the Criminal Justice System

Striving for objectivity in pursuing truth is a fundamental goal in forensic psychiatry. Forensic psychiatrists must, therefore, be aware of the potential areas of bias, including gender bias, in conducting evaluations. Evaluating persons for filicide, sexual offenses, sexual harassment, and intimate partner violence (or battered women syndrome) requires extra diligence or attention to the evaluator’s biases and knowledge about evidence-based gender differences.25

The role of gender in sentencing determination has fluctuated over time but has most consistently revealed more favorable sentences for women than men. Data from the United States Sentencing Commission found that female defendants receive shorter sentence outcomes than males.26 The gender disparities extend to interactions with the criminal justice system in general, not just sentencing. For example, women were less likely to be detained pretrial than men and were released with lower bond amounts than men.27 Women tend to be viewed as less dangerous and less likely to recidivate than men across a spectrum of criminal offenses, including violent and sexual offenses. Similarly, female defendants are more likely to be found not guilty by reason of insanity (NGRI) than male defendants and to be diverted to psychiatric facilities.28 In a study using case vignettes, forensic psychiatrists and students were more likely to find defendants NGRI when female. In contrast, judges found defendants of their own gender more likely to be NGRI.28

The role of gender bias or gender-held beliefs embedded in one’s culture may explain part of this discrepancy in legal outcomes. Studies have demonstrated that this gender bias affects outcomes, for example, showing that the gender of a perpetrator in a homicide or intimate partner violence changes a juror’s judgment.29 This gender bias may be pervasive, affecting many aspects of a criminal investigation. For example, gender bias has impacted the interpretation of crime scene evidence and eyewitness accounts.28,30 Alternatively, gender-related decisions may reflect the science of gender-relevant risk factors, such as the literature supporting female sex offenders as having a very low risk of reoffending.31

Research should guide whether discrepant decision-making based on gender is appropriate. To date, most of the risk assessment tools and outcomes have yet to be validated or studied explicitly in women. As a result, most risk assessment tools normed on males are adapted for women. Some tools have been studied and found to have good predictive accuracy in both male and female populations. The Level of Service Inventory (LSI), an actuarial tool for general offending, is one such tool.32 One of the most commonly used tools for violence assessment in psychiatric patients, the Historical, Clinical, Risk Management-20 (HCR-20), however, has low predictive validity for females.33 Tools that measure protective factors, such as the Structured Assessment of Protective Factors for violence risk (SAPROF), were found to be predictive in males but less predictive in females.34 The Psychopathy Checklist-Revised (PCL-R) has mixed results in the predictive accuracy of psychopathy in females compared with males.35 Developing gender-sensitive risk assessment tools, such as the Women’s Risk Needs Assessments (WRNA), is promising. Still, there is insufficient empirical evidence to establish a standard of care.36 In conclusion, risk assessment tools may be used as guidance in assessing women but should not be relied on as definite measures. Such tools should be regarded as one piece of data in an evaluation with limitations included in final opinions.

Youth: Girls in the Criminal Justice System

Phenomenology of Psychiatric Illness Among Females with Juvenile Justice Involvement

Existing literature has established that psychiatric disorders are more prevalent among justice-involved adults, with over-representation among females.37,–,39 Among justice-involved female children and adolescents, the prevalence of psychiatric problems is also elevated, with high rates of trauma and abuse, substance use, disruptive behavior, mood, and learning disorders, which are all thought to play a critical role in precipitating or perpetuating delinquent behaviors.40 Forensic psychiatrists evaluating and treating justice-involved women should be aware of these gender differences to provide evidence-informed and unbiased evaluations.

Young women who are justice-involved present with a unique constellation of risk factors, psychiatric vulnerabilities, and needs. They are more likely to have experienced sexual victimization, a depressive disorder, or high levels of parental conflict; come from dysfunctional homes; and be involved with an older male partner or friends.41,42 They most commonly will present in a noninstitutional setting, as courts tend to divert justice-involved females to the community.43 Children in postadjudication settings, such as residential placements, show higher rates of psychiatric problems than children in other settings,44 highlighting the complex interplay between serious delinquent behaviors and psychiatric illness.

Juvenile justice-involved females experience psychiatric disorders more than their male counterparts. McCabe and colleagues45 found that nearly two-thirds of adjudicated females experienced at least one Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) disorder compared with one-half of adjudicated males and one-third of a community sample. Other studies have found similar or even higher rates of psychiatric disorders.46 Studies examining the burden of psychiatric disorders in juvenile correctional facilities are not generalizable because of the limitations of small or male-only samples or examining a single psychiatric disorder. In contrast, the largest and only statewide census sample of committed youth found sex, race, or ethnic differences in the prevalence of psychiatric disorders, which was consistent with previous studies of both population types.47 Depressive disorders, bipolar disorder, and anxiety disorders, including posttraumatic stress disorder (PTSD), had a higher prevalence in females.47

Comorbidity is particularly important. Over half of the justice-involved female youths met the criteria for two or more disorders; thus, comorbidity is the norm.48 Abram48 also found that juvenile females had a greater chance of developing a substance use disorder than males if they had at least one other psychiatric diagnosis. Substance use prevalence tends to be similar between males and females, but girls generally show an earlier age of initiation and may show a more versatile pattern of use.49 Alcohol use is commonly reported, and this may be associated with the high rates of trauma and PTSD among girls.50,51 Mood disorders are also highly prevalent among justice-involved girls, occurring at higher rates than justice-involved males and at four or five times the rate of girls in the general population.52

Regarding suicide attempts and self-injurious behaviors, adolescent females engaging in delinquent acts also attempt suicide at higher rates than depressed female adolescents residing in the community (27-58% versus 20%).53,–,55 Nonsuicidal self-injury (NSSI) also occurs frequently. Up to 79 percent of self-injurers report a history of abuse or neglect.56,–,58 There is a limited literature base specifically examining rates and impact of NSSI within juvenile justice-involved populations in general. A small study by Chaplo et al.59 found that sexual abuse was a significant predictor of NSSI beyond other types of trauma. Justice-involved young females were much more likely to experience sexual abuse than males. NSSI functions as a self-regulatory mechanism in the context of stress and, often, posttraumatic symptoms.60

Experiences of neglect, violence, maltreatment, and abuse are the norm for justice-involved youth, with over 90 percent of youth reporting an experience of at least one trauma and a high proportion experiencing multiple traumas.61 Compared with males, females reported higher rates of sexual and physical abuse as well as polyvictimization.62,–,65 Because of the high number of justice-involved female youth who report sexual abuse, some researchers have hypothesized that childhood sexual abuse is a unique risk factor for future female delinquency.66

PTSD is nearly three times more prevalent among justice-involved girls than boys, similar to community samples, with girls experiencing a more severe symptom course than boys.45,64,67 A history of sexual abuse was more often found in girls with more extreme delinquency outcomes than those without.68,69 Early puberty is a risk factor for psychopathology, including delinquency, in females.70 It may be that early puberty leads to premature sexual experimentation and affiliation with older male peers and uncovering of mood or other psychiatric disorders.41 But early puberty could also be a marker for other risk factors for delinquency, such as sexual abuse. A few studies have established that women with sexual abuse histories tend to experience earlier menarche because of dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis.71,–,73 There is also an association between early menarche and physical abuse, although far less robust.72,74

Literature documenting reproductive health in detained youth is limited. Some studies estimate that between 20 to 40 percent of girls coming into the juvenile system have a documented sexually transmitted infection (STI), and they report higher numbers of sexual partners than girls in community samples.75,–,77 These risky sexual behaviors may be multifactorial, including poor access to health care and education, poverty, reactions to complex trauma, and, for some, prostitution. Substance use and depressed mood also increase the probability of high-risk behaviors.78 These girls’ sexual contact may be with older individuals; Lederman and colleagues documented that more than one-third of girls at a juvenile detention facility were sexually involved with someone at least five years their senior.79 For many detained girls, their incarcerated time represents their only contact with medical providers and potential reproductive counseling.80 Many detained girls also have health problems, including obesity, high rates of physical injuries, and other chronic medical conditions, which likely have been untreated or underdiagnosed because of poverty, parental neglect, abusive environments, or other factors.79 Some detained girls enter the juvenile system pregnant or may become pregnant while under community supervision, but the exact prevalence is unknown. Nearly one-quarter of detained girls reported a lifetime history of pregnancy.81 These health-related concerns are important considerations for forensic psychiatrists working with this population.

Other factors unique to female delinquents include higher rates of familial mental illness45 and a tendency to come from dysfunctional homes. Although limited by small sample sizes, Leve and Chamberlain reported that 70 percent of delinquent girls had at least one parent who had been convicted of a crime compared with 41 percent of males, but others have found family histories of antisocial personality to be similar between males and females.82 Girls may be more sensitive to relational elements and susceptible to harsh parenting, low warmth, maltreatment, and other factors. No distinct gender-specific pathway to delinquency has been uncovered.81 Additionally, disruptive females may be perceived as more deviant because of expected gender norms,83 thus evoking a harsher response from the primary caregiver. Even emotionally dysregulated infants may precipitate a harsher parental response, which may be relevant to the development of conduct disorder.84 Most girls, however, tend to follow an adolescent-onset and limited delinquent course, with a small proportion becoming persistent adult offenders.85

Long-term follow-up of justice-involved girls paints a bleak portrait. Well over half of these girls reported ongoing victimization into adulthood, especially at the hands of romantic partners.77 Many continued to engage in high-risk behaviors, such as drunk driving or carrying a gun, and had an increased risk of premature death. They were five times more likely to die violently compared with women in the general population.86

Legal Disposition of Justice-Involved Female Youths

The Office of Juvenile Justice and Delinquency Prevention (OJJDP) published a national report in 2019 relying upon data from the Federal Bureau of Investigation’s (FBI’s) Uniform Crime Reporting Program, OJJDP’s juvenile court data archive, and census of youth in residential placement. By 2015, arrests, petitioned delinquency cases, and status offenses or violations because of being a minor were at their lowest point in decades, following a peak in arrests and delinquency in the late 1990s to the early 2000s. Notably, however, the female proportion of arrests from 2006 to 2015 continued to rise to nearly one-third of total arrests.87 Overall, males accounted for a greater proportion of the arrests within each delinquent offense category, with one notable exception: prostitution, where young women accounted for 76 percent of arrests.

The typical female delinquency case involves a girl aged 15 or older who is of minority ethnicity and charged with a property offense; larceny or theft offenses are the most common.87 In girls younger than 15, offenses against people (rather than property) were most common. Girls accounted for a small proportion, less than one-fifth, of violent crime index offenses, which included rape, armed robbery, and aggravated assault. On the other hand, females accounted for 43 percent of status offenses (actions considered delinquent because of the juvenile’s age, which includes truancy, curfew violations, and running away), a much larger percentage than the delinquency caseload (28%). The typical female status offense involved a girl 15 years or older. The most common status offense for both males and females was truancy. Females accounted for more truancy and running away cases than did their male counterparts.

Across all offense categories, females were less likely to be detained and, even if referred to juvenile court, more likely to receive informal sanctions. When adjudicated, females usually received probation and were less likely to be placed in out-of-home placements. Public order violations, such as obstruction of justice, which included probation violations and escape from custody, were more likely to result in placement.87

Specialized Assessment and Treatment Approaches for Justice-Involved Female Youths

In response to the harmful effects of trauma on youth offenders and frontline staff, the U.S. Department of Justice has called for creating trauma-informed juvenile justice systems. A relative consensus regarding the core domains of a trauma-informed juvenile justice system exists in the literature, but there is much less agreement on the specific implementation and policies.88 When possible, health care and facility leadership staff should attempt to incorporate a coordinated multidisciplinary trauma-informed perspective in their diagnostic and treatment practices to enhance the quality of care for these youths. This perspective should include routine screening of youths for trauma exposure; evidence-based practice adopted by service providers; accessible resources on trauma to adolescent health care providers, youths, and their families; and consistency that there is a continuity of care across service systems.89

Important concerns that are particularly relevant with detained or adjudicated female youths include weighing the risks and benefits of the proposed psychotropic medication: the medication’s risk of overdose; pregnancy; and short- and long-term side effects, such as sedation and weight gain; anticipated youth compliance; the facility custody (if no health care staff are on site to administer); “cheeking” and trading medication for various reasons; and the parent or legal guardian’s reliability to supervise the youth’s medication and ensure follow-up psychiatric treatment. Other important variables to consider include prescription coverage, health plan benefits, and the potential for medication abuse and diversion (e.g., psychostimulants). The youth’s treating psychiatrist should consult with the youth’s treatment team and reassess the need for continuation or adjustments to various psychotropic medications based on compliance, side effects, current symptoms, level of functioning, and treatment needs. The clinical team, other relevant staff, and family members when appropriate should explore the circumstances and rationale for a youth’s pattern of medication refusal.90

Menstruation and Criminal Evaluations

Premenstrual tension was described in the medical literature by Frank, who described women who experienced emotional symptoms during the days preceding their menstrual cycle.91 The term “premenstrual syndrome (PMS)” was coined by Greene and Dalton, who described symptoms prior to the onset of the menstrual cycle, which could vary from mild to severe.93 Dalton and Green published their theory of “premenstrual syndrome” or PMS in British medical journals in 1953.93 Today, both the American Congress of Obstetrics and Gynecology and the American Psychiatric Association have developed overlapping but distinct disorders that constitute premenstrual disorders. Premenstrual disorders include psychiatric and somatic symptoms that develop during the luteal phase of the menstrual cycle, impair functioning, and resolve after the onset of menstruation. In the psychiatric literature, both the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) and the International Classification of Diseases, 11th revision (ICD-11) support the disorder as premenstrual dysphoric disorder (PMDD) and premenstrual tension syndrome (PMT).94 The DSM-5 diagnostic criteria for the diagnosis of PMDD comprise at least five predominately affective symptoms associated with functional impairment. The ICD-11, unlike the DSM, also includes the diagnosis of premenstrual tension syndrome (PMT). PMT is a more liberal diagnostic classification compared with PMDD, consisting of a severe form of premenstrual syndrome.95 The forensic considerations in the setting of premenstrual symptoms include the insanity defense, diminished capacity, mitigation, and aid in sentencing evaluations.

Available studies estimate the prevalence of PMS to be 20 to 30 percent and the prevalence of PMDD to be 1.2 to 6.4 percent.96,97 About 80 percent of women report at least one physical or psychiatric symptom during the premenstrual phase, but most do not report significant impairment in function.92 The prevalence of PMS is not associated with age, education, or employment status.92

Regarding etiology, the role of serotonin, modulated by estradiol, is supported by many studies and supports the role of selective serotonin reuptake inhibitors (SSRIs) in treatment.98 Imaging studies suggest differences in brain structure and function in women with PMDD and those without.99

PMDD is associated with both mood and anxiety disorders. Major depressive disorder was the most prevalent comorbid lifetime psychiatric disorder in women with PMDD.100 Women with trauma histories were more likely to have PMDD. Personality disorders were not associated with PMDD, but traits of impulsivity, anger, and affective lability were.101

Treatment for PMDD includes nonpharmacological approaches, such as lifestyle changes, including diet and exercise; psychotropic treatment, such as selective serotonin reuptake inhibitors (SSRIs); hormonal agonists and antagonists, surgery, and complementary medicines.92

Dalton described the three most common symptoms in women who had committed illegal acts as depression, irritability, and psychosis.102 Each of these symptoms can impact behavior, judgment, and impulsivity. Dalton and others suggested that more women commit crimes during the premenstrual period compared with other times in the menstrual cycle.103,–,105 A number of studies, however, question the validity of this.106

Langer, in “That Time of the Month–Premenstrual Dysphoric Disorder in the Criminal Law–Another Look,” contends that women with PMDD are eligible for legal defenses that address their culpability in this setting.107 The trial of Mary Harris in 1865 was the first U.S. case in which the defendant was found NGRI because of PMS.108 Mary Harris was nine years old when she met Professor Higgins. For the next seven years, they exchanged love letters. She moved to be with him in Chicago, and he was courting another woman by that time. She was enraged and began following him, eventually shooting and killing him in his office. Expert testimony included a forensic physician, who stated that Ms. Harris was insane from the combination of “being cursed in love and suffering from painful dysmenorrhea” at the time of the homicide.109 The jury deliberated for five minutes and acquitted Ms. Harris.

In the United Kingdom, the first major case using PMS as a mitigating factor was Regina v. Craddock in 1980.110 Sandie Craddock, a woman with 45 prior convictions, including theft, arson, and assault, was arrested for stabbing a fellow barmaid to death. Her psychiatric history was significant for multiple suicide attempts. The temporal relationship between Ms. Craddock’s menstrual cycles and suicide attempts was discovered by her attorney, who reviewed Ms. Craddock’s diaries, finding each criminal offense or suicide attempt occurred within her menstrual cycle. The expert for the defense, Dr. Dalton, diagnosed her with PMS and prescribed progesterone therapy. Ms. Craddock’s murder charge was reduced to manslaughter, and the trial court released her on probation with conditions that she continue treatment.

In 2013, PMDD was recognized in the DSM-5. Nonetheless, there still exists a great deal of controversy about using PMDD in the courtroom. The admissibility of PMDD remains a challenge despite including the diagnosis in the DSM-5 and ICD-11. To date, there is not universally accepted medical consensus on the etiology, symptomatology, or treatment of PMDD, and the reliability of diagnostic tools is challenged. Another concern among critics is the threat to a women’s credibility and thereby equality of women created by a PMS defense. Legal scholars and feminists warn that using the PMS defense will distort the view of women as deficient and bar their advancement in society. Furthermore, many critics fear that recognizing the PMS defense could stigmatize women as vulnerable to mental and physical instability. This stigma may be used against women in legal proceedings.

The use of premenstrual syndrome as a criminal defense should be informed by the case law in the jurisdiction and scientific data. The use of scientific data to demonstrate the validity of such a diagnosis, the use of standardized tools to show that the defendant experiences such a disorder, and the application of the legal standard are the core components of such an evaluation. An opinion supported by scientific data, as well as awareness of one’s potential biases, is important in safeguarding against an uninformed, biased opinion.

Postpartum: Criminal Evaluations

Baby Snatchers and Kidnapping by Cesarean

Regarding infant abductions, D’Orban111 described impulsive psychotic offenses, “comforting offenses,” and “manipulative offenses.” The impulsive psychotic offenses often included midlife women who had been unable to care for their children and believed that the infant was their own. The “comforting offenses” were noted to be “committed by young girls from deprived backgrounds with immature, hysterical personality traits, sometimes associated with mild mental handicap” (Ref. 112, p 196). Finally, the “manipulative offenses” were “committed with the intention to consolidate an insecure relationship with a man and influence his feelings, by pretending to him that he is the stolen child’s father” (Ref. 112, p 196). D’Orban112 noted “the motives underlying pseudocyesis include the need to secure a husband’s wavering affections and bolster a faltering marriage and to obtain a child as a plaything and companion. The motives are clearly similar to the motives found in the manipulative and the comforting types of child theft” (Ref. 112, p 197).

An investigation of hospital abductions of infants studied 77 American cases over the decade from 1983 to 1992. Seventy-three of those were returned safely within a fortnight. Rabun113 noted that almost all abductors were women who tended to be overweight and impersonating a nurse. Male partners were noted to be naive about infants and childbirth. The women often simulated pregnancies and nesting prior to the abductions and had histories of feigned pregnancies, miscarriages, and stillbirths. Almost half of the nonfamily infant abductions from 1983 to 2006 were taken from health care settings (47% were taken from the hospital, birth center, or pediatric clinic).114 Two-fifths (40%) were taken from homes. Almost all abductors were women, and almost half impersonated a health care worker. Almost one-fifth (18%) used violence, and 13 percent had made a previous attempt at abduction. Hospital staff thus play a key role in the prevention of hospital infant abduction.

Fetal abduction (also known as cesarean kidnapping) accounts for three percent of all infant abductions. The pregnant woman is usually killed prior to the removal of the fetus. The perpetrator uses a confidence-style approach. The abductor has usually faked a pregnancy and plans to dispose of the mother's body.115 Frierson115 noted that steps involved in fetal abduction include faking a pregnancy, identifying and contacting pregnant women, obtaining weapons for the murder and cesarean section, choosing a location, subduing and killing the mother, the cesarean section itself, disposing of the mother’s body, and finally, convincing others that the baby is hers.115 The abductor may trick others into believing she is pregnant by wearing padding, which simulates pregnancy, and researching how to feign positive pregnancy tests.

Fetal abductors will rarely meet legal criteria for insanity.115 The overwhelming majority of women who feign pregnancy do not become baby snatchers. There may be an elevated risk of suicide after a foiled attempt.115

Neonaticide and Safe Haven Laws

Neonaticide refers to child homicide on the first day of life.116 In neonaticide cases, the mother almost always acts alone, as the father is often no longer part of her life. Mothers who commit neonaticide are often in their teens or twenties, have limited resources, are unmarried, and with an unwanted pregnancy.117 They have rarely been diagnosed with a mental illness prior to the homicide, and suicide is rare in the western world among women who commit neonaticide.117 Neonaticides often occur after denial or concealment of pregnancy.117 Evolutionary psychiatry has been used as an explanatory model to help explain some child homicides as rational acts.117

Regarding neonaticide, it is important to consider where the study originated and the sample population. In general population studies, maternal perpetrators of neonaticide have been generally found to be single and young of lower socioeconomic status, living with their parents, experiencing denial or concealment of pregnancy and thus a lack of prenatal care, and fearful of repercussions.117 They tend to lack any serious mental illness prior to the offending,118 although they may develop PTSD, anxiety, or depression subsequently. A study of American neonaticide pretrial detainees primarily referred by defense attorneys for psychiatric evaluation found both denial of pregnancy and dissociative symptoms were often self-reported.119 No measure for malingering was able to be used, and the study relied on self-report measures.

Most neonaticides occur at home. Fathers rarely participate in neonaticides.120,121 Multiple women have committed serial neonaticides. DNA evidence has recently been used to identify women who years later were identified as neonaticide perpetrators.122

In America, Safe Haven Laws have existed since 1998 with the goal of decreasing rates of newborn abandonment and neonaticide. These now exist in all 50 states.118 Safe Havens vary in different states but may include hospitals, police stations, and fire stations as safe places for women to drop off their unwanted infants. Mothers will often remain anonymous and will not be prosecuted. Age ranges vary for Safe Havens, including infants under 72 hours old to up to a year old, depending on state and location. Data are not systematically available, but some studies suggest Safe Haven Laws may decrease the number of neonaticides. Neonaticides do still occur. It has been noted: “Women make quite different choices when they choose abandonment in a Safe Haven (hospital), abandonment in a place where the infant is not likely to be found (trash receptacle), and neonaticide. It may be different groups of women who act in these different ways” (Ref. 118, p 45).

Opposition to Safe Haven laws includes that it may potentially encourage women to conceal their pregnancies and to birth infants outside hospitals unsafely, thereby encouraging abandonment. Another concern is that these laws are not well publicized and thus are not well known by the population in need of them. Outside of the United States, other prevention methods are used, such as anonymous free delivery of unwanted babies in France. Also, baby hatches exist at similar locations (hospitals) outside of the United States, where mothers can safely relinquish their unwanted infant unharmed.118

Infanticide, Infanticide Acts, and Filicide

Infanticide and filicide both involve the murder of one’s child. Infanticide is a less precise term, which overlaps a legal definition that only includes certain mothers who kill their infant up to one year of age. Filicide includes child murder by the parent, usually up to age 18, while the child is still living in a dependent relationship with the parent.120

Although the United States does not have an Infanticide Act, approximately two dozen countries other than the United States, including Canada, have an Infanticide Act. These laws decrease penalties for mothers who kill their child within the first year of life in general, although in parts of Australia and New Zealand, the law includes older children.117 The 24 nations that have Infanticide Acts, tend to follow the original British Infanticide Act of 1922 (amended in 1938). This act has allowed mothers to be charged with what is akin to manslaughter rather than murder if they were experiencing a mental disturbance at the time that they killed their infant under age one. Initially, this law was based on the concept of “lactational insanity.” Historically, women servants killed their infants, whom they could not look after and still work. The public has often given leniency to women who are convicted of infanticide; women will often receive sentences of probation and referral to mental health treatment rather than incarceration.123 Those criticizing infanticide laws often point out the following: fathers are not eligible, the life of the child may be devalued, and a woman in the same mental state may kill a young child under age one and an older child and would only be eligible for infanticide for one of the children killed.117,123

Identification and treatment of parental mental illness, personality disorders, and substance use disorders is part of prevention of infanticide. Infanticide is related to mental illness in some cases. When postpartum psychosis is not treated, the risk of both suicide and infanticide rises, as well as the risk of child maltreatment. This risk of child maltreatment may be because of the mother’s confused or delusional thinking.124 It is critical to understand whether the mother’s hallucinations and delusions involve the infant; infanticidal ideas and behaviors have both been associated with a mother having psychotic thoughts about her infant.125

In addition to parental risk factors, risk factors in the infant or child that may increase the risk of maltreatment and death include colic, autism, and developmental disability.126

In evaluating filicide research, it is vital to consider that common factors among mothers or fathers who kill vary depending on the type of population studied. For example, jail and correctional studies will have different expected results than studies of mothers in the forensic hospital and coroner studies or general population studies.120 What is commonly found among mothers who kill is “a pattern of powerlessness, poverty, and alienation” (Ref. 120, p 1582).

When evaluating international studies about filicide, caution must be used because rates across countries may significantly differ related to societal and cultural differences.128 In the United States, infant homicide rates are higher than in most countries. A recent study129 found that those children at the highest risk of being killed in Denmark included young children whose mothers had been hospitalized because of mood disorders or schizophrenia. To decrease the risk of filicide, as one does with other types of violence, one should consider the various static and dynamic risk factors.128

General population studies of women who killed their children often demonstrate that these mothers are socially isolated, have poor socioeconomic status, and are full-time caregivers who may have been violently victimized themselves.123 Persistent crying or other child factors were sometimes the described precipitant to the filicide. Substance misuse often occurred in this group as well. Mental illness may or may not have occurred in this group.123 In the corrections population, mothers who killed tended to be similarly unemployed victims of abuse themselves who had limited social support and education. Mental health concerns and substance use concerns were also noted, as were multiple stressors. Finally, and alternatively, in psychiatric samples of women who had killed their children, studies found frequent psychosis, suicidality, depression, and a history of mental healthcare. Some personality disorders and some intellectual disorders were noted. Significant life stressors were common.123

In a study regarding psychiatrists’ knowledge about maternal thoughts of child harm, most psychiatrists underestimated how often depressed mothers experienced thoughts of harming their child. Approximately one-half of the psychiatrists indicated that they did not ask specifically about filicidal thoughts but rather asked about general homicidal thoughts.130 Asking mothers about filicidal thoughts is critical in performing risk assessments.

When filicide is committed jointly with suicide, mental illness may often have been involved. Although many mothers attempt suicide with filicide, just as in suicide cases, women may be less likely to die by suicide than men based on the attempted method. Fathers and mothers commit filicide at similar rates,117 yet fathers are approximately twice as likely to commit filicide-suicide.120,131,132

Regarding infanticide and filicide motives, not all are related to serious mental illness. Resnick116 described the five motives for filicide in a categorization that remains commonly used today. The five motives currently include fatal maltreatment, unwanted child, partner revenge, altruistic, and acutely psychotic.123 Fatal maltreatment is the most common cause of child murder and occurs as the result of abuse or neglect, which is often chronic.117,124 In an unwanted child case, they are unwanted, such as because of inconvenience or other plans for a new partner or new life. Partner revenge is meant to cause psychological pain and suffering in the other surviving parent, such as during custody battles. In distinction, in altruistic filicide, parents, often with a psychotic or depressive disorder, kill their children out of their perception of what love is, believing that they’re preventing suffering on Earth, or kill a child when they are themselves suicidal to prevent that child from being parentless. Finally, in acutely psychotic filicide cases, parents kill their child for no comprehensible motive. This may occur in response to command hallucinations or in confusion or delirium. The final two motives: altruistic and acutely psychotic, are most likely related to a serious mental illness whereas the others may or may not involve serious mental health problems.123

When completing a not guilty by reason of insanity (NGRI) evaluation for filicide, the definition of the cognitive prong in the case or statutory law of the jurisdiction should be considered. In addition to the routine assessment of collateral records, additional records that may be useful include prenatal care records, pediatrics records, and Child Protective Services records.117 Recommendations for questions in a comprehensive interview after filicide are outlined in the Friedman et al.133 chapter on writing a maternal filicide report.

In cases of fatal maltreatment, there may be mental illness, but there may also be evidence of personality disorder, anger problems, intellectual disability, or substance use.117 Similarly, in unwanted child cases, there is often an absence of severe mental illness. Parents who engage in partner revenge filicide may have a personality disorder. Regarding altruistic filicide cases, these parents often experience a psychotic disorder or depressive disorder, and similarly, parents with acutely psychotic filicide often have a psychotic disorder.

Among mothers found NGRI in two American states, almost three-quarters had previous treatment by mental health care providers.134 Over two-thirds were experiencing auditory hallucinations, frequently command hallucinations. Approximately half were depressed at the time of the filicide. Almost three-quarters experienced considerable developmental stressors, including incest or the death of their mother, for example. The motives among the mothers found Not Guilty by Reason of Insanity were predominately considered altruistic motives or acutely psychotic motives.134

Correctional Facilities and Forensic Hospitals: Reproduction

Pregnancy

Rates and Pregnancy Testing

A significant number of women in the United States are confined to either correctional institutions or psychiatric hospitals. In recent decades, the number of women incarcerated in the United States has risen dramatically from 26,378 in 1980 to 222,455 in 2019, with most of these women being within their reproductive years.135,136 Even higher numbers of women enter mental health facilities each year, with approximately 400,000 women of childbearing age being psychiatrically hospitalized in 2016.137 Data on pregnancy among incarcerated or psychiatrically hospitalized women are sparse because of inconsistent screening and reporting practices in these settings.137,138 It is estimated that anywhere from three to ten percent of female inmates are pregnant at the time of admission to a correctional institution,136,138 and no statistics regarding pregnancy rates among psychiatric inpatients are available in the current literature.

Pregnancy testing is needed when a woman is admitted to a correctional or psychiatric facility because reports of sexual, contraceptive, and menstrual histories are often unreliable.139 Up to 80 percent of female inmates endorse heterosexual activity in the weeks leading up to incarceration, with less than 30 percent using a reliable form of contraception.140 Knowledge of pregnancy status upon admission to either a correctional or a mental health facility is crucial to providing timely initiation of prenatal care, counseling regarding abortion or adoption, identifying women at risk of pregnancy-related complications, ensuring appropriate activity restrictions (e.g., work and bunk assignments), analyzing risks and benefits of treatment decisions, and minimizing risks of adverse pregnancy outcomes related to medication use and other interventions.136,141

Despite being an important aspect of medical evaluation, pregnancy testing is not uniform across correctional or inpatient psychiatric facilities, with a recent report showing less than 40 percent of jails routinely obtaining pregnancy tests at intake142 and pregnancy testing rates ranging from 59 percent to 94 percent upon admission to psychiatric hospitals.137 Screening for pregnancy has been identified as a high-priority measure to improve the quality of inpatient psychiatric care,137 and several organizations, including the American College of Obstetricians and Gynecologists (ACOG) and the National Commission on Correctional Health Care (NCCHC), have recommended that all women of reproductive age be offered pregnancy testing upon reception to correctional institutions.141,143 Even when pregnancy testing is negative, screening upon incarceration or psychiatric hospitalization allows providers to discuss family planning strategies with a group of women at increased risk for unintended pregnancies.137,144

Abortion Access

Women with psychiatric illnesses and women in the criminal justice system have elevated rates of unplanned pregnancies.144,145 Being incarcerated or psychiatrically hospitalized does not preclude a woman’s legal right to abortion, although the state in which she is hospitalized may restrict abortion access. Timely access to abortion for these populations is often inconsistent and unreliable because of variations in policies, ill-defined counseling practices, concerns about potential coercion, and logistical challenges involving appointment scheduling, transportation, and payment.146,–,148 In some instances, abortion is viewed as an elective procedure and therefore denied until a woman’s release, resulting in delays in care.147 Given the time restrictions on pregnancy termination, abortion should be considered a medically necessary procedure and arranged as expeditiously as possible.147

Informed consent is especially important when abortion is being considered, given that the procedure is time-sensitive and irreversible and that the decision-making process may be complicated by conflicting opinions among stakeholders, sociopolitical controversies, and strong emotional reactions from patients or clinicians.149 Consenting to abortion should be assessed similarly to the capacity to consent to any significant, permanent medical procedure.150 Preabortion counseling should be comprehensive and nondirective.149

Contraception

Psychiatric hospitalization and incarceration both offer an opportunity to provide family planning services to women whose reproductive health care needs often go unmet.145,147,151 Taking a sexual history upon admission may allow for the use of emergency contraception. A study of newly arrested women found that nearly 30 percent were eligible for emergency contraception, and of those, almost half indicated a willingness to take emergency contraception if available.152 In surveys of female inmates in Rhode Island, half of the respondents indicated they did not wish to become pregnant. Less than 30 percent reported consistent preincarceration birth control use, over 80 percent had prior unintended pregnancies, 35 to 40 percent had previous abortions, and over 80 percent anticipated resuming sexual activity after release.145,147 Studies have found that female inmates are amenable to starting contraception during incarceration and are much more likely to initiate birth control when provided free of charge by the correctional institution rather than postrelease.145,147 ACOG recommends that all incarcerated women be offered services for contraceptive methods, including emergency contraception, based on the medical need to minimize the risk of unintended pregnancy.141

Like incarcerated women, women with serious mental illness have relatively low rates of contraceptive use compared with the general population and high rates of unintended pregnancies.151 Women with psychiatric illness may have limited access to obstetrical or gynecological services, and contact with mental health care providers may serve as their only opportunity to address reproductive needs.151 Many mental healthcare clinicians do not routinely discuss birth control with their patients.153

Female permanent contraception, or tubal ligation, is one of the most common methods of birth control used by women in the United States.154 Permanent sterilization among incarcerated women and women with psychiatric illnesses has a dubious history and raises several ethics concerns relating to informed consent and coercion. Long-acting reversible contraceptives (LARCs) are extremely effective in preventing pregnancy, have high continuation rates, and may be a more suitable alternative in these populations.151 Admission to a correctional facility or psychiatric hospital is an opportune time to address family planning in a population at risk for unintended pregnancy and other adverse reproductive health outcomes.

Pregnancy Management

Providing prenatal care to women in correctional and psychiatric settings poses several challenges because of complex logistics and conflicts between institutional priorities and health care needs. Treatment is often shared between facility medical staff and community obstetrical providers, and problems may arise involving transportation, coordination of care, and delays in obtaining emergency services. Security presence during appointments may give rise to confidentiality concerns. Furthermore, women housed in correctional or psychiatric institutions lack control over their surroundings, including noise levels, clothing, food choices, sleep schedules, and the timing of meals and snacks, which may exacerbate pregnancy-related discomfort.

Community standards for prenatal care apply to women who are incarcerated or psychiatrically hospitalized141,155 and include pregnancy testing; pregnancy counseling; access to abortion; evaluation and treatment of substance misuse, HIV, and depression; provision of appropriate vitamins and nutrition; and delivery in a hospital with facilities for high-risk pregnancies.141 The National Commission on Correctional Health Care (NCCHC) and the Federal Bureau of Prisons have set similar standards. Yet compliance with such guidelines is variable across institutions, with shortcomings identified in a wide range of areas, including pregnancy testing at intake; access to abortion; provision of prenatal, labor and delivery, and postpartum care; HIV treatment; mental health services; nutrition and vitamin supplementation; special accommodations; substance misuse treatment; and pregnancy outcomes reporting.143,156,157

Perinatal Medication Treatment in Prison and Forensic Hospitals

For further details about prescribing for women in corrections, please refer to Friedman et al.2 When treating mental illness during pregnancy, the psychiatrist should consider the risks and benefits of the medication to the mother and the dyad.158 Potential medication risks during pregnancy include elevated rates of miscarriage, congenital malformation, premature delivery, perinatal syndromes (withdrawal or toxicity), and behavioral teratogenesis. Risks and benefits to both the mother and the infant should also be considered in lactation, as the vast majority of medications will pass into breastmilk.158 The psychiatrist must weigh the risks of the specific medication with the risks of not treating mental illness, which may include violence, suicide, and not taking care of oneself or obtaining proper prenatal care.

In a correctional or forensic hospital environment, the psychiatrist should coordinate with other medical professionals, such as obstetricians and pediatricians. For those women with new onset of depressive symptoms in the mild range during pregnancy, psychotherapy alone, with close follow-up and a proactive approach and planning to start medication if symptoms worsen, may be appropriate. Although a full discussion of medication use during pregnancy and postpartum is outside of the scope of this document, the psychiatrist should be aware that, for depression during pregnancy and the postpartum, SSRIs are the first-line agents, in particular sertraline and citalopram, which have relatively good safety profiles during pregnancy. Paroxetine is not a preferred treatment in pregnancy for major depressive illness because of its potential for increased rates of infant cardiac malformation.158 Readers are also referred to the “Treatment and Management of Mental Health Conditions During Pregnancy and Postpartum Clinical Practice Guidelines” published by the American Colleague of Obstetricians and Gynecologists.159

Among women with bipolar disorder or schizophrenia, olanzapine and quetiapine are commonly used in pregnancy.160,–,162 Where possible, the use of multiple agents should be avoided because of a paucity of research on polypharmacy and the potential for increased risk of adverse effects.

Pregnancy Outcomes

Data regarding births and pregnancy outcomes in U.S. correctional and psychiatric settings are minimal. No pregnancy-related reporting requirements have been standardized or mandated across American systems.140 A study from 1998 found 1,400 births across 43 state prisons.140 More recently, a survey of 12 months of pregnancy statistics from 22 state prisons and the Federal Bureau of Prisons reported 1,396 pregnancies with 753 live births (92% of outcomes), 46 miscarriages (6%), 11 abortions (1%), four stillbirths (.5%), two ectopic pregnancies (.25%), three newborn deaths, and no maternal deaths.140

Compared with the general U.S. population, incarcerated women and women with mental illness have higher rates of adverse pregnancy outcomes, including prematurity and low birthweight.13,163 When compared with similarly disadvantaged groups, depending on the timing of incarceration, imprisoned women may have improved outcomes with less prematurity, fewer stillbirths, and higher birth weights, suggesting some aspects of confinement, such as adequate housing, regular nutrition, and forced sobriety, may be health promoting among this vulnerable population.140,163,–,165 Relatively positive birth outcomes in correctional populations should be interpreted within the context of broader social determinants of health.140 To date, there is no systematic published data regarding pregnancy outcomes among forensically psychiatrically hospitalized women.

Use of Restraints

Using restraints among pregnant inmates and psychiatric inpatients is controversial.166 A restraint is defined as any manual method that immobilizes or limits the movement of a person’s arms, legs, body, or head.167 The main reason for restraint use is to prevent escape (correctional) or harm to self or others (psychiatric).136 In correctional settings, shackling or restraints are routinely used during transport and may include ankle cuffs, handcuffs, or belly chains.133 In psychiatric hospitals, soft restraints, restraint masks, or fabric body holders are used during behavioral crises.167 Many organizations, including the American Civil Liberties Union, the American Psychological Association, and ACOG, have opposed the routine use of restraints among pregnant women in corrections.136 Restraints in pregnancy may have potential adverse health effects, including impaired mobility, discomfort, increased risk of falls, delays in care during obstetrical emergencies, increased risk of blood clots, decreased placental blood flow, and interference with labor and delivery.141,168 Restraints should be used only when there is an imminent risk of harm to the pregnant woman, her fetus or newborn, or others and only when less-restrictive alternatives, such as verbal de-escalation or increased staffing, are unsuccessful.169,170

Postpartum and Parenting

Postpartum Epidemiology and Presentation of Postpartum Depression and Postpartum Psychosis

Postpartum depression is common, with rates as high as one in five mothers.171 Although the DSM-5 requires the symptoms to begin within a month postpartum for diagnosis, the window of vulnerability is often the entire first year postpartum, which has the highest risk of suicide for women.172 Like in pregnancy, symptoms are often missed or overlooked, yet the impact is on the woman, the infant, and the entire family unit. Recognizing the difference between postpartum depression and the “baby blues” is important. The latter is very common, upward of three-quarters of postpartum women experience a several-day period of irritability and heightened emotions related to the hormonal changes and sleep deprivation of the postpartum period.173 This typically resolves by the end of the second week postpartum and is not associated with more concerning symptoms, such as thoughts of death or difficulty with baby bonding.

Several risk factors can predispose someone to postpartum depression. These include biological and genetic vulnerabilities, such as a history of depression, family history of postpartum mood conditions, or experience with other hormonally mediated conditions, such as premenstrual dysphoria.174 These also include social and psychological risk factors, such as ambivalence about the pregnancy and relationship and family conflict or interpersonal violence. A difficult or traumatic delivery, poor pain management, and challenges with breastfeeding may also contribute to the risk of postpartum depression.175

There is also a substantial percentage of women who are labeled as treatment-resistant depression who have a bipolar spectrum condition. In a multicenter study of first-episode depression (n = 885), 15 percent of those with first-onset postpartum episodes met DSM-IV criteria for bipolar disorder. In comparison, only five percent of those with first-onset nonpostpartum episodes did.176

Bipolar disorder is the most common underlying diagnosis for a presentation of postpartum psychosis, a condition affecting about one to two per 1,000 women, with a high risk of recurrence and often onsetting shortly after delivery.177 Untreated postpartum psychosis carries with it risks of suicide and infanticide.124 It can often manifest with a delirium-like presentation, with confusion, disorientation, and depersonalization, making recognizing the diagnosis more challenging.178

It is also important not to confuse postpartum psychosis, because of its inherent risks, and postpartum obsessive-compulsive disorder (OCD), with intrusive, distressing thoughts.124 With the latter, the intrusive thoughts, often of harm befalling the baby or other family, possibly at the hands of the mother, are ego-dystonic and distressing to the woman. In contrast, with postpartum psychosis or certain personality conditions, the thoughts of self or other harm can be ego-syntonic and are cause for clinical concern.

Forced Separation and Custody Loss

Approximately three-quarters of the women incarcerated in the United States are mothers. In contrast to fathers in custody, who often rely on their children’s mothers for childcare, many incarcerated women are single parents lacking paternal support.136,179 Few U.S. correctional facilities (and no forensic psychiatric hospitals) allow children to coreside with their mothers, meaning that most children of incarcerated or hospitalized mothers will be placed with a family member, a friend, a foster home, or given up for adoption.136 While in custody, mothers may maintain contact with their children through letters, telephone calls, video conferences, and face-to-face visits. Fewer than half of incarcerated women have in-person visits with their children for various reasons, including transportation problems, prohibitive geographic distances, facility environment not being child friendly, security procedures, and short visitation times.136

Under the Adoption and Safe Families Act of 1997, mothers with no family to care for their children and who are incarcerated for more than 15 months may have parental rights permanently terminated, regardless of parenting abilities.136,180 Separation can be detrimental to mothers and their children, leading to psychological harm and possibly increasing recidivism rates for female offenders.180 NCCHC recommends facilities support efforts for women to maintain contact with their children and recognize the distress that separation may cause incarcerated women and their children.143 Forensic psychiatrists may be asked to opine about the appropriateness of such contact.

Breastfeeding

The benefits of breastfeeding have been well documented, and many organizations, including the American Academy of Pediatrics and ACOG, recommend exclusive breastfeeding for the first six months of life.181,182 Incarcerated or psychiatrically hospitalized women face barriers to breastfeeding, including physical separation from the infant, lack of access to breast pump and storage equipment, lack of privacy, and lack of lactation support and education.136,183 Additionally, female inmates and women with serious mental illness often have demographic characteristics (such as low income, unstable housing, or substance misuse) that decrease the likelihood of breastfeeding.183 Furthermore, potential effects of psychiatric medications on the newborn may cause concern among postpartum women and caregivers, and deter breastfeeding initiation in these populations.184 Information regarding prescribing for incarcerated women in the postpartum period has been previously published in JAAPL,2 and the reader is referred there. Studies of incarcerated mothers have shown that they often view breastfeeding as important and may derive psychological benefits from it.183,185 NCCHC has recommended that correctional facilities, wherever possible and not precluded by security concerns, devise systems to enable postpartum women to express breastmilk and directly breastfeed.186 Doula support programs have been shown to promote breastfeeding among incarcerated women.183

Medication Treatment in the Postpartum

During breastfeeding in the postpartum, polypharmacy should similarly be avoided where possible. The preferred antidepressant in lactation is sertraline. Olanzapine or quetiapine are common prescribed antipsychotics in mothers with bipolar disorder or psychotic symptoms.118 Careful documentation of the mother’s thinking and the informed consent process should be completed. Finally, sedation as a side effect should be considered among mothers who need to care for their infant at night, for example, in mother-baby units of correctional facilities or under community control.

Mother-Baby Units and Visitation

The United Nations Children’s Fund (UNICEF) noted that mothers and infants should not be separated because of incarceration, related to the child’s best interest and the right to family life. Many nations outside the United States offer mother-baby units (MBUs). MBUs are currently offered in 10 states.136 In Canada, depending on the jurisdiction and other factors, children may remain with their mothers until age four, seven, or 12.136 The cost of housing a child in a prison nursery is similar to that of foster care.187

MBUs allow children to live with their mothers in correctional facilities until 12 or 18 months of age. Specific criteria must be met in order for a mother to participate, such as not having a history of child maltreatment or being incarcerated for a non-violent offense. MBUs should include a child-friendly environment and focus on the relationship between the mother and the baby. “In theory, goals for MBUs should include providing a supportive environment and training for improved parenting, improved attachment, and decreased recidivism related to the importance of the mothering role” (Ref. 136, p 369).

It is recommended that postpartum mothers be screened for (and treated for) maternal mental illness. As well, Child Protective Services can assist in determining whether MBU placement is appropriate for the mother and infant.136 Current studies indicate that mothers separated from their infants are more likely to be reincarcerated and to recidivate.136 An American study of infants at prison nursery programs demonstrated that most developed secure attachment, which increased if they were in the MBU longer. This occurred even despite a mother’s attachment style being insecure.188 There are arguments against MBUs, including the concern about the child’s rights, the suggested risk of incentivizing pregnancy, and an unnatural custodial environment for the child.136

Because many incarcerated women have been living as the head of a single-parent household the month before their arrest, there may often be a lack of paternal support upon the mother’s incarceration. This is a gender difference because most incarcerated fathers identify the child’s mother as the primary caretaker.133,189 Children are then often placed in grandparental care, foster care, and adoption.

Despite efforts, there may be limited contact with children when women are incarcerated, and children of incarcerated mothers are known to subsequently experience increased rates of depression, anxiety, and criminality.190 Parenting classes are offered in many prisons. There are fewer women’s prisons than men’s, and they may be located in isolated areas far from population centers. This may make it difficult for the children of prisoners to visit their mothers in prison. This creates a problem, as contact while the mother is incarcerated predicts successful reunification once the mother is released from prison.191

Menopause and Aging Women in Forensic Hospitals and Corrections

Adults over 65 are predicted to comprise nearly a quarter of the American population by 2060,193 as medical care and treatment advances have dramatically increased the human lifespan. With increasing age comes a higher incidence of physical illness and an increased risk for neuropsychiatric disorders, such as minor neurocognitive disorder (mNCD) and major neurocognitive disorder (MNCD). The presence of these disorders as well as psychiatric and physical disorders are important considerations in performing forensic evaluations for older populations. Treating severe mental illness in menopause may also require specialized training or experience, as symptoms and treatment response can vary.194

Effects of Menopause

Menopause is a transitional period when decreased estrogen levels can be associated with both increased physical symptoms as well as mood and psychotic symptoms.195 The menopause transition generally starts around the age of 47 and lasts four to seven years.195 Physical symptoms may include irregular menstrual periods, hot flashes, night sweats, sleep disturbance, sexual dysfunction, and elevated risk of osteoporosis and cardiovascular disease.195 Psychiatric symptoms may worsen during menopause, including more frequent symptoms of depression and a worsening of schizophrenia.195

Health problems related to menopause are the third most common reported health concern in older women in prison.196 Women are at increased risk of developing mood symptoms during perimenopause, especially women with an earlier history of depressive disorders.197 For women, absent a prior history of depression, symptoms of depression were more than twice as likely to occur during the menopausal transition than premenopause.198 Risk factors for developing depressive symptoms in menopause include a history of depression, vasomotor symptoms, sleep disturbances, surgical menopause, early age at menopause, negative attitudes about aging and menopause, and concurrent life stressors.195

Women with severe mental illness, such as schizoaffective disorder, schizophrenia, bipolar disorder, or major depressive disorder, reported significant vasomotor, physical, sexual, and psychosocial symptoms related to menopause.195,199 As well, women have a second peak of onset of schizophrenia after age 45, corresponding to the onset of menopause.195,200

Medication dosage may need to be adjusted in menopause to maintain efficacy. The decreasing hormonal levels associated with menopause may affect drug metabolism. Some metabolizing enzymes are estrogen dependent. Other factors affecting drug metabolism and efficacy in older women include polypharmacy, alcohol, illicit drugs, liver mass, smoking, caffeine, and nutritional intake.195

Pudas et al.201 noted that, by midlife, changes in biological sex and sex-hormone-mediated memory circuitry become apparent. These changes during menopause may explain cognitive decline during aging.202 Compared with premenopausal women, postmenopausal women show different hippocampal responses during verbal memory tasks.203,204

Diagnostic accuracy is important when treating or performing evaluations of older women. Depression and other reversible conditions can be mistaken for neurocognitive disorder (NCD) in older women. A careful differential diagnosis should be considered when evaluating patients with suspected NCD.

In elderly women, the first symptoms of physical illness often are psychological or behavioral in nature. The onset of delirium can signify the presence of infection or other somatic conditions.205 Treatable medical conditions can be misdiagnosed as functional NCDs in older women.206

Aging Women in Corrections

Both the male and female prison population declined from 2018 to 2019. The number of males declined by two percent from year-end 2018 to year-end 2019. The number of women declined by almost three percent over the same period. Males accounted for 92 percent of the total prison population and females eight percent.207 Despite the overall decrease in the number of inmates, certain subgroups of the prison population are increasing. Persons older than 50 are the fastest growing segment of the prison population.208 Between 1990 and 2014, the number of prisoners over 50 had grown by more than 50 percent.209 Several factors have contributed to this increase: mandatory prison sentences, three-strikes legislation resulting in a sentence of life in prison after the third felony, and longer sentences.210,211

Over the last 40 years, female incarceration rates in state prisons have risen substantially for all ages.212 A contributing factor is the increased involvement in the criminal justice system of white women charged with violent, property, and drug-related offenses.213

The increase in the aging population, coupled with the increase in the female population, has combined to produce a substantial increase in the subgroup of older female inmates.212 In California alone, the number of geriatric female prisoners increased by 350 percent between 1996 and 2006.214 In 2019, 3.2 percent of male prisoners and 1.6 percent of female prisoners sentenced to more than a year were 65 or older. Approximately 15.4 percent of women sentenced to more than a year were age 50 and older.215

Because of the accelerated aging of the prison population associated with earlier development of disability, most correctional systems and facilities use the age of 50 or 55 to assign inmates to the geriatric population.216,–,218 Those over 50 require enhanced medical services and support resources.211

Older female inmates have more chronic illnesses than nonincarcerated women and have higher rates of psychosocial stressors.2,214 Inmates 55 and older have higher rates of hypertension, respiratory disease, and arthritis compared with women in the general population who are 65 and older.196 Compared with their age-matched male inmates, older female inmates have worse physical health, more frequently disclose mental health problems,219 and have higher rates of comorbidities than men.214

Neurocognitive Disorders among Aging Female Prisoners

Women have increased risks of developing Alzheimer’s disease (AD) compared with men.220,221 Several risk factors for neurocognitive disorder occur more frequently in the female incarcerated populations than in the general population. These include head injury, depression, obesity, and substance misuse.2 Several studies strongly indicate that females with AD are more affected by disease processes than their male counterparts.222,223 Compared with men, women with AD demonstrated a greater decline in essentially all cognitive domains than AD men.224

Twenty-eight percent of geriatric female prisoners studied in California reported memory loss, and 69 percent reported at least one impairment of Prison Activities of Daily Living (PADLs).214

Because of the incidence of cognitive deficits in the aging populations, it is recommended that the standard patient screening and assessment process be expanded to include a standardized, objective screening measure of cognitive ability, such as the Mini-Mental State Examination and the Montreal Cognitive Assessments.211 The “start low, go slow” strategy when prescribing cholinesterase inhibitors can help decrease the frequency of adverse events in the geriatric population, especially in women.225 Serious events occurring immediately after initiating cholinesterase inhibitor therapy were associated with the higher starting dose. This association was stronger in women.225 Estrogen is not considered a prophylactic treatment for dementia.2

Prescribing in Geriatric Female Inmates

The same concerns about prescribing for the general geriatric population apply to the correctional population. Prescribing for geriatric patients requires attention to risks because of the prevalence of underlying medical conditions; heightened sensitivity to medication side effects, particularly in women; and the potential for drug-drug interactions.226 Risks are further increased by medical multimorbidity and polypharmacy, which are more frequent in aging women.227 Polypharmacy increases the risk of adverse events and iatrogenic harm.228 Side effects can affect cognition.211

Housing Older Females

Older women present unique physical and mental health problems that institutions must address to meet their health care needs. In addition to access to care problems, female inmates with a neurocognitive disorder or physical limitations may be subject to disciplinary actions when cognitive and physical impairment goes unrecognized.218

Handtke et al.229 recommended tailored social and health interventions that address the specific needs of elderly women. Data were collected from two prisons in Switzerland housing women prisoners. Three main areas of particular vulnerability were identified: the status of “double minority” (being a woman and being elderly), health and health care access, and social relations.229 Aging women can be vulnerable to victimization by other younger inmates. There are separate housing units for older men; many advocate for these specialized units for women.212

A national pilot study of federal and state prisons for women looked at services available to older women. The authors found that prisons reported supplying basic physical and mental healthcare services and most reported providing hospice services. Prisons housing larger percentages (or expecting to house larger percentages) of older female prisoners did not significantly differ in their approaches to assessing and providing healthcare compared with their counterparts. Enhanced services were recommended.230

Barry et al.212 conducted focus groups with health care workers in the Connecticut State Department of Corrections for Women to better understand the unique health care needs of older women prisoners. They identified challenges in caring for older women. These women had multiple comorbidities and exhibited cognitive or communication deficits, and they needed more intensive levels of care and higher staffing levels. The healthcare workers reported difficulty finding a balance in providing the appropriate level of empathy, given this restriction within the prison system. The healthcare workers recommended that more resources needed to be allotted for mental health needs for this age group.212

There are also challenges in ensuring compliance with out-of-facility medical referrals. Barry212 noted that elderly female prisoners were reluctant to travel offsite for medical care and refused treatment. The same van used for medical appointments first dropped off defendants for court appearances. Being in the van with young and disruptive defendants was very distressing to the older women, who preferred to forgo care rather than ride in the van.

Correctional facilities have to deal with the challenge of caring for persons requiring nursing home levels of care and training staff to treat older populations. Alternatives such as specialized nursing units for women are being considered. Early release programs may be appropriate for severely physically and mentally compromised inmates.211

Addiction in the Criminal Justice System at Different Stages of Women’s Reproductive Age

Although women represent the minority of those under the criminal justice system’s supervision, their involvement rate increased by more than 100 percent from 1990 to 2000. This was partly because of the war on drugs in the United States, which disproportionately impacted women. In 1980, one in 10 women was incarcerated for a drug-related offense, and this number had magnified to one in three by 2000.231 The average woman incarcerated in America even today is a nonviolent property offender who uses alcohol, drugs, or both. This renders the matter of substance use disorders in the reproductive woman important to forensic psychiatrists working in correctional settings.

Compared with male counterparts, women in the criminal justice system are more likely to experience psychiatric disorders. Depending on the population studied, they are as likely to experience alcohol and drug use disorders. The higher prevalence of alcohol and drug use in women compared with men in the community erodes in criminal-justice-involved populations. Especially early on (i.e., jails), rates of nonalcohol substance use disorders may be higher in incarcerated women.232 Women experience a phenomenon called “telescoping,” in which significant symptoms evolve more rapidly from the onset of tolerance.233 Interventions such as contingency management, motivational interviewing, case management, integrated longitudinal services, and pharmacotherapy, are all likely to benefit this population.

Civil Evaluations

Pregnancy

Malpractice Evaluations in Pregnancy

When treating pregnant women with mental health problems, psychiatrists need to be aware of both the risks of failure to treat as well as the potential risks from treatment with medication. Should a forensic psychiatrist be involved in a malpractice lawsuit in this area, both of these concerns should be considered in addition to routine items considered in a malpractice case.149,158,234 Risks of untreated mental illness in pregnancy include suicide, infanticide, preeclampsia, poor prenatal care, increased risk of fetal exposure to drugs or alcohol, fetal exposure to maternal cortisol levels, preterm delivery, low birth weight, and failure to thrive. Just as there are reasons that serious mental illness is treated at any point in life, there are compelling reasons to treat mental illness during pregnancy, whether with medication, psychotherapy, or both. The psychiatrist should be aware that, in any evaluation of treatment during pregnancy and the postpartum period, no medication is without potential risk. All pregnancies have risks, even when the mother has done everything right. For example, approximately three percent of pregnancies in America yield infants with malformations.158 When the psychiatrist is treating a pregnant woman with medications, considerations include the potential risk of miscarriage, risk of malformation, preterm delivery, perinatal toxicity, and behavioral teratogenesis.158

Approximately 13 percent of pregnant women are prescribed antidepressant medications. Those with severe or moderate depression are more likely to require treatment with antidepressants than those with mild symptoms.158 Rational medication decisions, informed consent, and good documentation are most important when treating pregnant women. The involvement of the patient’s partner and family in the discussion helps improve compliance and potentially reduce misunderstandings and disagreements about treatment. Medication management in pregnancy is largely outside of the scope of this document, but the reader is referred to Friedman et al.2 In general, older medications for which there are more data available are more appropriate to utilize in pregnancy than brand new medications.158 Exposure to agents of concern is often most critical in the first trimester of pregnancy during organogenesis. Other medications that cause the potential for withdrawal in the newly delivered infant may be considered problematic in the third trimester. Polypharmacy should be minimized in pregnancy where possible because of the potential multiplicative rather than the additive effect of two agents. Monotherapy should be considered where possible, as well as using a medication the patient has previously done well on. The lowest effective dose should be used.158 Further, half of all pregnancies are unplanned; thus, many patients become pregnant under the care of a psychiatrist.158 This should be considered when treating all women of reproductive age, and when possible, medications should be chosen that are safe in case she becomes pregnant.

Women may consider discontinuation of psychotropic medications upon learning they are pregnant. Women who stop their antidepressants during pregnancy are more likely to experience a relapse than those who continue their medication. Cohen et al.235 found that 26 percent of those continuing their antidepressants during pregnancy relapsed, compared with over two-thirds (68%) who had stopped the medication. Viguera and colleagues236 considered recurrence rates after discontinuation of mood-stabilizing medications, finding 52 percent recurrence within 40 weeks after lithium discontinuation during pregnancy (58% for nonpregnant). Postpartum recurrences were more frequent than those among nonpregnant women after the length of pregnancy. Recurrence risk was higher among those with rapid (rather than gradual) discontinuation. The effects of depression on infant development, as well as the mother-infant attachment, both need to be considered.

A major ethical and malpractice concern occurring during pregnancy and the postpartum includes the psychiatrist’s failure to treat the pregnant woman because of concerns about bad outcomes. Specifically, doctors may believe that, when a negative outcome occurs related to an intervention, it is different than when a negative outcome occurs because of an illness.237,238 “Omission bias occurs because doctors are more concerned about acts of commission (if treatment were to lead to a negative outcome) than acts of omission (not treating a patient’s illness). When one is cognizant of this potential bias, one may address it— such that one ensures equal discussion of risks of treating and the risks of leaving maternal depression untreated” (Ref. 286, p 82).

Negative outcomes during pregnancy leading to malpractice cases may include a suicide or a homicide, an infant malformation, or another negative outcome. Suicide and homicide cases may allege the failure of the psychiatrist to treat. Evaluating forensic psychiatrists must consider, as the treating psychiatrist should have, the risks and benefits of various courses of action regarding treatment and whether the treating physician informed the mother of those risks. It is important that forensic psychiatrists be aware of the research, including recent research regarding valproic acid and lithium, which are never completely contraindicated in pregnancy or lactation.240,241 Working knowledge of the state of the literature is important. A reproductive psychiatry consult should be obtained when necessary and feasible.228

Forced Medications in Pregnancy

Women with mental illness have increased risks of negative outcomes from pregnancy.8 Schizophrenia has been associated with having infants who are premature, small, or large for gestational age, as well as maternal preeclampsia.13 Additional risk factors found more commonly among women with serious mental illness include illicit substance use, use of alcohol, or smoking while pregnant. Women with serious mental illness also have elevated victimization rates and poor prenatal care.242 Each of these is a risk factor for negative outcomes of pregnancy.

In completing evaluations for involuntary treatment in pregnancy, the following have been recommended8: the evaluating psychiatrist must be aware of the model used for involuntary treatment consideration in the state where the treating psychiatrist practices. The woman’s diagnosis, the rationale regarding the need for treatments with consideration of current knowledge about the use of antipsychotic and mood-stabilizing medication and pregnancy (including the risk in a specific trimester of pregnancy), the concerns about why capacity is lacking, and the least restrictive alternatives as far as treatment are important. The forensic psychiatrist should also understand potential pregnancy complications stemming from both untreated illness and treatment. In forensic reports, the harms of no treatment for mental illness should be described, as well as the risk of medications. Further, communication with staff in obstetrics and pediatrics is important. Friedman and colleagues (Ref. 8, p 222) also note, “if feasible, for involuntary medication orders in pregnancy, oral medications or possibly short-acting injectable antipsychotics are preferred over long-acting injections”. Forensic psychiatrists must “consider their own biases and potential biases or fears of others involved in the process” (Ref. 8, p 222). This includes treatment team members, the woman’s family, and the legal system.

Substance Use During Pregnancy

The use of substances during pregnancy has been shown to result in adverse infant health outcomes, including drug dependence, miscarriage, premature birth, low birth rate, and behavioral and cognitive problems.243 Treatment options for mothers who misuse substances during pregnancy include voluntary and involuntary treatment. Depending on the jurisdiction, pregnant mothers may be involuntarily civilly committed or placed in the protective custody of the state for treatment based on the risk of danger to the unborn infant. States also vary in mandated reporting requirements in cases of mothers misusing substances during pregnancy. At the time of authoring this document, 20 states have laws requiring health care providers to report perinatal substance use to child protective services and four states mandate health care providers to report only when the provider believes the substance misuse resulted in child maltreatment.244

Diagnosis of Eating Disorders and Pregnancy

Eating disorders are more common in women, with a lifetime prevalence of 8.4 percent compared with 2.2 percent in men.245 Eating disorders are serious psychiatric illnesses associated with high rates of medical morbidity and mortality. Apart from deaths from opioid abuse, eating disorders have the highest mortality rates of any psychiatric illness,246 both because of the medical complications of eating disorders as well as from suicide.247 Patients with severe and enduring eating disorders are a subgroup with longstanding and life-threatening disorders. These patients have a low likelihood of recovery, poor adaptive function, high levels of symptoms, and comorbid physical and psychological illnesses, and require the regular attention of a multidisciplinary team.248,–,250 Treatment providers must therefore be realistic about the prognosis given the low odds of a cure and adjust treatment expectations accordingly.251 Thus, managing this subgroup of patients may require trying a novel treatment modality and a shift in the goal of treatment from cure to harm reduction or ultimately to palliative or hospice care.

The bulk, 90 percent, of eating disorders develop before age 25.252 Individuals with anorexia nervosa are also more likely to become pregnant at a young age compared with individuals who do not have an eating disorder.253,254 Indicators of a suspected eating disorder include failure to achieve or maintain an appropriate weight for age and height; intense fear of gaining weight; preoccupation with feeling fat; abnormal electrolytes, such as a low serum potassium level;252 oligomenorrhea; amenorrhea; and inadequate weight gain in pregnancy.255

Although the absence of menstruation is no longer required for the diagnosis of anorexia nervosa, the resumption of menses is still seen as a hallmark of recovery. Despite weight gain, amenorrhea persists in 15-35 percent of women with anorexia, possibly because of either a high level of exercise or anxiety.256,257

The prevalence of eating disorders in pregnant or breastfeeding women is about five percent.258 Despite the absence of menses in many patients, women with anorexia nervosa are twice as likely to have an unplanned pregnancy, whereas women with bulimia have a 30-fold increased risk of unplanned pregnancies compared with the general population.259

Pregnant women with eating disorders are at high risk for poor nutrition during pregnancy and negative birth outcomes, including spontaneous abortion, preterm labor, and obstetrical complications.260,–,262 They have a greater risk of having infants with low birth weight, smaller head circumference, microcephaly, intrauterine growth restriction, and perinatal mortality.263 Pregnant women with eating disorders are often younger than those without eating disorders, and they are more likely to experience higher pregnancy-related maternal and perinatal morbidity and mortality than older adult women.264

For those who refuse treatment for their eating disorders during pregnancy, involuntary psychiatric care may be considered, especially if the patient presents an imminent danger to herself or her unborn child or meets the statutory definition for grave disability in that particular state (e.g., if a woman is not able to provide adequate nutrition for herself).265 If the woman is too ill to take care of her infant after birth, consideration should be made for contacting Child Protective Services.

Capacity and Decision-Making in Eating Disorders

Guardianship and involuntary psychiatric commitment are legal measures utilized to compel treatment. Both measures require the individual to lack capacity. In most jurisdictions, guardianship does not grant a guardian the power to admit the ward to a mental health facility without the ward’s consent. Furthermore, the courts can only authorize ongoing psychiatric care and nutritional rehabilitation under commitment laws once the respondent is no longer medically compromised.265

Because therapeutic alliance is an important predictor of achieving a target weight and remaining in treatment, treatment providers often hesitate to initiate involuntary treatment.266,267 These concerns must be weighed against concerns regarding future morbidity and mortality if a patient with severe anorexia nervosa continues to refuse life-saving care.268

A harm-reduction approach must consider several ethics matters to ensure clinicians understand the needs of a pregnant patient at a given time and make clinical decisions based on the jurisdictional standard of treatment decision-making. Principles such as “first do no harm” and respecting patients’ right to self-determination (taking capacity for decision-making into account) should be used as guides.

Misconceptions about Child Abuse and Custody Loss

Child maltreatment includes physical abuse, neglect, sexual abuse, and emotional abuse. Historically, there is a 10-fold difference between the prevalence of self-reported child maltreatment and the actual number of cases reported to Child Protective Services.269,270 In the United States, psychiatrists and physicians are mandatory reporters of child abuse and neglect. Psychiatrists should report to Child Protective Services (CPS) if there is a reasonable suspicion of abuse, neglect, or significant risk to the child.270 Hospitalization should also be considered if there is concern about the risk of child abuse or infanticide related to acute mental illness.

Psychiatrists should be certain to be aware if their patients are parents and if they have custody of their children.130 Approximately one-half of women with serious mental illness are parents; approximately 10 to 20 percent of those with serious mental illness have children living in their homes.270,–,272 Further, approximately one-half of parents with schizophrenia eventually lose custody of their children.273 In total, approximately one-quarter of mothers with serious mental illness may lose child custody.274 Parents who fear the loss of custody may be hesitant to report mental health symptoms and parenting difficulties, leading to less treatment for this vulnerable population.270,275

Although it is often suggested that mental illness leads to child maltreatment, such risk is decreased by treatment of symptoms and psychosocial support.270 Studies of mental illness and child maltreatment are often fraught with methodological problems, including a lack of definition for mental health problems, a lack of definition for violence, or a conflation of scales.270 Symptoms related to mental illness that may lead to increased child maltreatment risk may include the negative symptoms, disorganized thinking, paranoia, or hallucinations of schizophrenia; decreased motivation and energy in depression; or irritability, impulsivity, and poor judgment in mania. Treatment that reduces symptoms, would be expected to reduce the risk of violence.270 A recent reanalysis of the MacArthur violence risk database indicated that, compared with their community counterparts, parents with severe mental illness who were being treated were not at increased risk toward a child. Thus, being involved in psychiatric care may be protective against child maltreatment,270 similar to how treatment helps protect from other forms of violence.

Competency for Abortion

Although the right to abortion was decided by the U.S. Supreme Court in Roe v. Wade276 in 1973, the Dobbs v. Jackson Women’s Health Organization277 in 2022 held that the Constitution does not confer a right to abortion. As evidenced by the Supreme Court’s decision-making, abortion remains controversial across the United States. Case law based on Roe v. Wade may be in question post-Dobbs. The forensic psychiatrist may be called upon in cases of abortion regarding the woman’s capacity to consent to pregnancy termination.278 Evaluations may occur among women who have been diagnosed with psychiatric illness, with intellectual disability, or who are minors. These evaluations should be approached similarly to evaluations for other types of medical procedures. The psychiatrist performing such an evaluation acts in accordance with the principles of informed consent assessments and the same principles as performing other evaluations, not letting one’s own opinions about abortion become part of the evaluation. Whether an evaluator is prochoice or antiabortion, the evaluator should examine personal biases in these cases.25,150

Data that purport that women who have abortions are more likely to have long-term negative mental health outcomes are often based on studies that have multiple methodological problems.150 The control group for studies examining associations with abortions should be women of similar socioeconomic status and histories who sought abortions but could not procure them. When other control groups are used, such as married women with planned pregnancies, these are not true controls. The interested reader is referred to Friedman et al.150 for further discussion of the potential forensic evaluations related to abortion.

For juveniles in various states, forensic psychiatrists may be involved in assessing whether young women under the age of 18 who are pregnant qualify for judicial bypass of parental consent or parental notification for pregnancy termination. In states where abortion remains accessible and legal post-Dobbs, parental consent laws, including judicial bypass procedures, remain in effect unless legislatures pass new laws or in cases where abortion may be banned for the state. For example, in Ohio, the juvenile court may find that a pregnant minor, with clear and convincing evidence, may be “sufficiently mature and well enough informed to intelligently decide whether to have an abortion” or may find that notification of her parents is “not in her best interest” (Ref. 239, p 401) for her to bypass parental consent for abortion. Neither term has been consistently defined in this context, and scholarship in this area has been limited.239 Friedman and colleagues239 found that, among a sample of teenage women presenting for evaluation for judicial bypass, most were age 16 or over, worked part-time as well as attending school, and were involved in long-term romantic relationships with the involved male, who was only slightly older than they were at the time. Although the majority had consulted with a trusted adult regarding their options of continuing pregnancy, pregnancy termination, or adoption, the person they consulted with was not their parent. Friedman and colleagues (Ref. 239, p 403) noted that “even with the politically-charged nature of these procedures, the overwhelming majority (95%) were granted a judicial bypass. However, this may represent a selection bias for those pregnant minors who were persistent, proactive, assertive, and informed about the judicial bypass option, have better nonparental supports, and who are better able to overcome the barriers of this challenging process.” Multiple other barriers occur, making abortion more difficult for teens, such as getting away from school and obtaining transportation.279,280

Elder Abuse and Neglect in Women

One in six or 68 million aging women experience abuse worldwide according to a global systematic review and meta-analysis of abuse of women aged 60 and up.281 In most jurisdictions, physicians are mandated reporters of elder abuse or neglect.282,283 States’ definitions of elder abuse vary.282 Elder abuse may include physical, psychological, sexual, or financial abuse and neglect.283,284 About 11 percent of community-residing older adults experienced abuse within the past year.285 Victim risk factors include physical and mental health problems, substance misuse, dependency on the victim or caregiver, stress and poor coping skills, attitudes, negative beliefs, prior abuse victimization, and relationship problems.284

Conclusions

In summary, understanding women’s reproductive mental health is critical for many types of criminal and civil forensic evaluations and treating women in various states of life in corrections. It is also critical that forensic psychiatrists examine their potential for gender bias in such evaluations. Forensic evaluations related to child murder by parents (both afterward and in completing risk assessments), child abuse, and forced medication in pregnancy all benefit from reproductive psychiatry knowledge. Forensic psychiatrists in treatment roles in forensic hospitals and correctional environments should also hone their understanding of mental illnesses in pregnancy, postpartum, lactation, and menopause to best serve a growing part of their patient populations.

Footnotes

  • Reviewed by Jeffrey S. Janofsky, MD, Medical Director, AAPL, and Debra A. Pinals, MD, Medical Director, AAPL.

  • © 2024 American Academy of Psychiatry and the Law

References

  1. 1.
    1. Tamburello A,
    2. Penn J,
    3. Ford E
    et al. The American Academy of Psychiatry and the Law practice resource for prescribing in corrections. J Am Acad Psychiatry Law. 2022 Dec; 50(4):636–7
  2. 2.
    1. Friedman SH,
    2. Tamburello AC,
    3. Kaempf A,
    4. Hall RCW
    . Prescribing for women in corrections. J Am Acad Psychiatry Law. 2019 Dec; 47(4):476–85
  3. 3.
    1. Abel KM,
    2. Ramsay R.
    The Female Mind: A User's Guide. London, U.K.: RC Psych Publications; 2017
  4. 4.
    1. Lewis C
    . Treating incarcerated women: Gender matters. Psychiatr Clin North Am. 2006 Sep; 29(3):773–89
  5. 5.
    1. Macdonald M
    . Women prisoners, mental health, violence and abuse. Int’l J L & Psychiatry. 2013 May-Aug; 36(3-4):293–303
  6. 6.
    1. McDaniels-Wilson C,
    2. Belknap J
    . The extensive sexual violation and sexual abuse histories of incarcerated women. Violence Against Women. 2008 Oct; 14(10):1090–127
  7. 7.
    1. Zlotnick C
    . Antisocial personality disorder, affect dysregulation and childhood abuse among incarcerated women. J Pers Disord. 1999 Spring; 13(1):90–5
  8. 8.
    1. Friedman SH,
    2. Hall RCW,
    3. Sorrentino RM
    . Involuntary treatment of psychosis in pregnancy. J Am Acad Psychiatry Law. 2018 Jun; 46(2):217–23
  9. 9.
    1. Gentile S
    . Untreated depression during pregnancy: Short- and long-term effects in offspring. A systematic review. Neuroscience. 2017 Feb; 342:154–66
  10. 10.
    1. Grote NK,
    2. Bridge JA,
    3. Gavin AR
    et al. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry. 2010 Oct; 67(10):1012–24
  11. 11.
    1. Goodman JH,
    2. Chenausky KL,
    3. Freeman MP
    . Anxiety disorders during pregnancy: A systematic review. J Clin Psychiatry. 2014 Oct; 75(10):e1153–84
  12. 12.
    1. Rusner M,
    2. Berg M,
    3. Begley C
    . Bipolar disorder in pregnancy and childbirth: A systematic review of outcomes. BMJ Pregnancy Childbirth. 2016 Oct; 16:331
  13. 13.
    1. Vigod SN,
    2. Kurdyak PA,
    3. Dennis CL
    et al. Maternal and newborn outcomes among women with schizophrenia: A retrospective population-based cohort study. BJOG. 2014 Apr; 121(5):566–74
  14. 14.
    1. Neugebauer R,
    2. Kline J,
    3. Shrout P
    et al. Major depressive disorder in the 6 months after miscarriage. JAMA. 1997 Feb; 277(5):383–8
  15. 15.
    1. Blackmore ER,
    2. Côté-Arsenault D,
    3. Tang W
    et al. Previous prenatal loss as a predictor of perinatal depression and anxiety. Br J Psychiatry. 2011 May; 198(5):373–8
  16. 16.
    1. Nynas J,
    2. Narang P,
    3. Kolikonda MK,
    4. Lippmann S
    . Depression and anxiety following early pregnancy loss: Recommendations for primary care providers. Prim Care Companion CNS Disord. 2015 Jan; 17(1):10.4088/PCC.14r01721
  17. 17.
    1. Weng S-C,
    2. Chang J-C,
    3. Yeh M-K
    et al. Do stillbirth, miscarriage, and termination of pregnancy increase risks of attempted and completed suicide within a year? A population-based nested case-control study. BJOG. 2018 Jul; 125(8):983–90
  18. 18.
    1. Biggs MA,
    2. Upadhyay UD,
    3. McCulloch CE,
    4. Foster DG
    . Women’s mental health and well-being 5 years after receiving or being denied an abortion. A prospective, longitudinal cohort study. JAMA Psychiatry. 2017 Feb; 74(2):169–78
  19. 19.
    1. Steinberg JR,
    2. Laursen TM,
    3. Adler NE
    et al. The association between first abortion and first-time non-fatal suicide attempt: A longitudinal cohort study of Danish population registries. Lancet Psychiatry. 2019 Dec; 6(12):1031–8
  20. 20.
    1. Yadav T,
    2. Balhara YPS,
    3. Kataria DK
    . Pseudocyesis versus delusion of pregnancy: Differential diagnoses to be kept in mind. Indian J Psychol Med. 2012 Jan; 34(1):82–4
  21. 21.
    1. Seeman MV
    . Pseudocyesis, delusional pregnancy, and psychosis: The birth of a delusion. World J Clin Cases. 2014 Aug; 2(8):338–44
  22. 22.
    1. Spinelli MG
    1. Miller LJ
    . Denial of pregnancy. In Spinelli MG, editor. Infanticide: Psychosocial and Legal Perspectives on Mothers Who Kill. Washington DC: American Psychiatric Publishing; 2003. p. 81–104
  23. 23.
    1. Wessel J,
    2. Buscher U
    . Denial of pregnancy: Population based study. BMJ. 2002 Feb; 324:458
  24. 24.
    1. Friedman SH,
    2. Heneghan A,
    3. Rosenthal M
    . Characteristics of women who deny or conceal pregnancy. Psychosomatics. 2007 Mar-Apr; 48(2):117–22
  25. 25.
    1. Friedman SH
    . Searching for the whole truth: Considering culture and gender in forensic psychiatric practice. J Am Acad Psychiatry Law. 2023 Mar; 51(1):23–34
  26. 26.
    1. Doerner JK,
    2. Demuth S
    . Gender and sentencing in the federal courts: Are women treated more leniently? Crim Just Pol’y Rev. 2012 Jan; 25(2):242–69
  27. 27.
    1. Goulette N,
    2. Wooldredge J,
    3. Frank J,
    4. Travis L
    . From initial appearance to sentencing: Do female defendants experience disparate treatment? J Crim Just. 2015 Sep-Oct; 43(5):406–17
  28. 28.
    1. Yourstone J,
    2. Lindholm T,
    3. Grann M,
    4. Svenson O
    . Evidence of gender bias in legal insanity evaluations: A case vignette study of clinicians, judges, and students. Nord J Psychiatry. 2008; 62:273–8
  29. 29.
    1. Feather NT
    . Domestic violence, gender, and perceptions of justice. Sex Roles. 1996 Oct; 35(7-8):507–19
  30. 30.
    1. Nakhaeizadeh S,
    2. Morgan RM,
    3. Rando C,
    4. Dror IE
    . Cascading bias of initial exposure to information at the crime scene to the subsequent evaluation of skeletal remains. J Forensic Sci. 2018 Mar; 63(2):403–11
  31. 31.
    1. Cortoni F,
    2. Hanson RK,
    3. Coache M-È
    . The recidivism rates of female sexual offenders are low: A meta-analysis. Sex Abuse. 2010 Dec; 22(4):387–401
  32. 32.
    1. Olver ME,
    2. Stockdale KC,
    3. Wormith JS
    . Thirty years of research on the level of service scales: A meta-analytic examination of predictive accuracy and sources of variability. Psychol Assess. 2014 Mar; 26(1):156–76
  33. 33.
    1. Garcia-Mansilla A,
    2. Rosenfeld B,
    3. Cruise KR
    . Violence risk assessment and women: Predictive accuracy of the HCR-20 in a civil psychiatric sample. Behav Sci & L. 2011 Sep-Oct; 29(5):623–33
  34. 34.
    1. de Vries RM,
    2. Vogel V,
    3. Stam J
    . Protective factors for violence risk: Assessment with the SAPROF. Psychology. 2012 Jan; 3:1259–63
  35. 35.
    1. Häkkänen-Nyholm H,
    2. Nyholm J.-O
    1. Logan C,
    2. Weizmann-Henelius G
    . Psychopathy in women: Presentation, assessment, and management. In Häkkänen-Nyholm H, Nyholm J.-O, editors. Psychopathy and Law: A Practitioner’s Guide. Singapore: Wiley-Blackwell; 2012. p. 99–125
  36. 36.
    1. de Vogel V,
    2. Bruggeman M,
    3. Lancel M
    . Gender-sensitive violence risk assessment: Predictive validity of six tools in female forensic psychiatric patients. Crim Just & Behav. 2019 Jan; 46(4):528–49
  37. 37.
    1. Teplin LA,
    2. Abram KM,
    3. McClelland GM
    . Prevalence of psychiatric disorders among incarcerated women. I. Pretrial jail detainees. Arch Gen Psychiatry. 1996 Jun; 53(6):505–12
  38. 38.
    1. James DJ,
    2. Glaze LE
    . Mental health problems of prison and jail inmates. Bureau of Justice Statistics Special Reports [Internet]; 2006 Sep. Available from: https://www.ojp.gov/ncjrs/virtual-library/abstracts/mental-health-problems-prison-and-jail-inmates. Accessed April 29, 2023
  39. 39.
    1. Steadman HJ,
    2. Osher FC,
    3. Robbins PC
    et al. Prevalence of serious mental illness among jail inmates. Psychiatr Serv. 2009 Jun; 60(6):761–5
  40. 40.
    1. Teplin LA,
    2. Abram KM,
    3. McClelland GM
    et al. Psychiatric disorders in youth in juvenile detention. Arch Gen Psychiatry. 2002 Dec; 59(12):1133–43
  41. 41.
    1. Zahn-Waxler C,
    2. Shirtcliff EA,
    3. Marceau K
    . Disorders of childhood and adolescence: Gender and psychopathology. Annu Rev Clin Psychol. 2008 Feb; 4:275–303
  42. 42.
    1. Solomon BJ
    . Other-sex friendship involvement among delinquent adolescent females. Youth Violence Juv Justice. 2006 Jan; 4(1):75–96
  43. 43.
    1. Puzzanchera C,
    2. Hockenberry S
    . Juvenile court statistics, 2018 [Internet]; 2020 Jun. Available from: https://ojjdp.ojp.gov/library/publications/juvenile-court-statistics-2018. Accessed April 30, 2023
  44. 44.
    1. Wasserman GA,
    2. McReynolds LS,
    3. Schwalbe CS
    et al. Psychiatric disorder, comorbidity, and suicidal behavior in juvenile justice youth. Crim Just & Behav. 2010 Dec; 37(12):1361–76
  45. 45.
    1. McCabe KM,
    2. Lansing AE,
    3. Garland A,
    4. Hough R
    . Gender differences in psychopathology, functional impairment, and familial risk factors among adjudicated delinquents. J Am Acad Child Adolesc Psychiatry. 2002 Jul; 41(7):860–7
  46. 46.
    1. Bonham E
    . Adolescent mental health and the juvenile justice system. Pediatr Nurs. 2006 Nov-Dec; 32:591–5
  47. 47.
    1. Harzke AJ,
    2. Baillargeon J,
    3. Baillargeon G
    et al. Prevalence of psychiatric disorders in the Texas juvenile correctional system. J Correct Health Care. 2012 Apr; 18(2):143–57
  48. 48.
    1. Abram KM,
    2. Teplin LA,
    3. McClelland GM,
    4. Dulcan MK
    . Comorbid psychiatric disorders in youth in juvenile detention. Arch Gen Psychiatry. 2003 Nov; 60(11):1097–108
  49. 49.
    1. McCuish E
    . Substance use profiles among juvenile offenders: A lifestyles theoretical perspective [Internet]; 2017 Jan 1. Available from: https://www.crimrxiv.com/pub/sleicvt5. Accessed April 29, 2023
  50. 50.
    1. Kilpatrick DG,
    2. Ruggiero KJ,
    3. Acierno R
    et al. Violence and risk of PTSD, major depression, substance misuse/dependence, and comorbidity: Results from the National Survey of Adolescents. J Consult Clin Psychol. 2003 Aug; 71(4):692–700
  51. 51.
    1. Tillman KS,
    2. Prazak MD
    . Trauma in forensic adolescent females: Predictors, correlates and mental health outcomes. J Child Adolesc Trauma. 2018 Dec; 11(4):401–9
  52. 52.
    1. Fazel S,
    2. Doll H,
    3. Långström N
    . Mental disorders among adolescents in juvenile detention and correctional facilities: A systematic review and metaregression analysis of 25 surveys. J Am Acad Child Adolesc Psychiatry. 2008 Sep; 47(9):1010–9
  53. 53.
    1. Abram KM,
    2. Choe JY,
    3. Washburn JJ
    et al. Suicidal ideation and behaviors among youths in juvenile detention. J Am Acad Child Adolesc Psychiatry. 2008 Mar; 47(3):291–300
  54. 54.
    1. Rohde P,
    2. Lewinsohn PM,
    3. Klein DN
    et al. Key characteristics of major depressive disorder occurring in childhood, adolescence, emerging adulthood, and adulthood. Clin Psychol Sci. 2013 Jan; 1(1):41–53
  55. 55.
    1. Rohde P,
    2. Mace DE,
    3. Seeley JR
    . The association of psychiatric disorders with suicide attempts in a juvenile delinquent sample. Crim Behav & Mental Health. 1997; 7(3):187–200
  56. 56.
    1. Gratz KL,
    2. Conrad SD,
    3. Roemer L
    . Risk factors for deliberate self-harm among college students. Am J Orthopsychiatry. 2002 Jan; 72(1):128–40
  57. 57.
    1. Gratz KL
    . Risk factors for deliberate self-harm among female college students: The role and interaction of childhood maltreatment, emotional inexpressivity, and affect intensity/reactivity. Am J Orthopsychiatry. 2006 Apr; 76(2):238–50
  58. 58.
    1. Yates TM,
    2. Tracy AJ,
    3. Luthar SS
    . Nonsuicidal self-injury among “privileged” youths: Longitudinal and cross-sectional approaches to developmental process. J Consult Clin Psychol. 2008 Feb; 76(1):52–62
  59. 59.
    1. Chaplo SD,
    2. Kerig PK,
    3. Bennett DC,
    4. Modrowski CA
    . The roles of emotion dysregulation and dissociation in the association between sexual abuse and self-injury among juvenile justice-involved youth. J Trauma Dissociation. 2015; 16(3):272–85
  60. 60.
    1. Klonsky ED,
    2. Glenn CR
    . Assessing the functions of non-suicidal self-injury: Psychometric properties of the Inventory of Statements About Self-injury (ISAS). J Psychopathol Behav Assess. 2009 Sep; 31(3):215–9
  61. 61.
    1. Abram KM,
    2. Teplin LA,
    3. King DC
    et al. PTSD, trauma, and comorbid psychiatric disorders in detained youth [Internet]; 2013 Jun. Available from: https://ojjdp.ojp.gov/sites/g/files/xyckuh176/files/pubs/239603.pdf. Accessed April 29, 2023
  62. 62.
    1. Smith DK,
    2. Leve LD,
    3. Chamberlain P
    . Adolescent girls’ offending and health-risking sexual behavior: The predictive role of trauma. Child Maltreat. 2006 Nov; 11(4):346–53
  63. 63.
    1. Martin D,
    2. Martin M,
    3. Dell R
    et al. Profile of incarcerated juveniles: Comparison of male and female offenders. Adolescence. 2008 Fall; 43(171):607–22
  64. 64.
    1. Kerig PK,
    2. Vanderzee KL,
    3. Becker SP,
    4. Ward RM
    . Deconstructing PTSD: Traumatic experiences, posttraumatic symptom clusters, and mental health problems among delinquent youth. Journ Child Adol Trauma. 2012 Jan; 5(2):129–44
  65. 65.
    1. Ford JD,
    2. Elhai JD,
    3. Connor DF,
    4. Frueh BC
    . Poly-victimization and risk of posttraumatic, depressive, and substance use disorders and involvement in delinquency in a national sample of adolescents. J Adolesc Health. 2010 Jun; 46(6):545–52
  66. 66.
    1. Siegel JA,
    2. Williams LM
    . The relationship between child sexual abuse and female delinquency and crime: A prospective study. J Res Crime & Delinq. 2003 Feb; 40(1):71–94
  67. 67.
    1. McLaughlin KA,
    2. Koenen KC,
    3. Hill ED
    et al. Trauma exposure and posttraumatic stress disorder in a national sample of adolescents. J Am Acad Child Adolesc Psychiatry. 2013 Aug; 52(8):815–30.e14
  68. 68.
    1. Goodkind S,
    2. Ng I,
    3. Sarri RC
    . The impact of sexual abuse in the lives of young women involved or at risk of involvement with the juvenile justice system. Violence Against Women. 2006 May; 12(5):456–77
  69. 69.
    1. Wareham J,
    2. Dembo R
    . A longitudinal study of psychological functioning among juvenile offenders: A latent growth model analysis. Crim Just & Behav. 2007 Feb; 34(2):259–73
  70. 70.
    1. Ge X,
    2. Conger RD,
    3. Elder GH Jr.
    Coming of age too early: Pubertal influences on girls’ vulnerability to psychological distress. Child Dev. 1996 Dec; 67(6):3386–400
  71. 71.
    1. Heim C,
    2. Nemeroff CB
    . The role of childhood trauma in the neurobiology of mood and anxiety disorders: Preclinical and clinical studies. Biol Psychiatry. 2001 Jun; 49(12):1023–39
  72. 72.
    1. Wise LA,
    2. Palmer JR,
    3. Rothman EF,
    4. Rosenberg L
    . Childhood abuse and early menarche: Findings from the black women’s health study. Am J Public Health. 2009 Oct; 99(Suppl 2):S460–6
  73. 73.
    1. Putnam FW,
    2. Trickett PK
    . Psychobiological effects of sexual abuse. A longitudinal study. Ann NY Acad Sci. 1997; 821:150–9
  74. 74.
    1. Hayward C
    1. Bergevin TA,
    2. Bukowski WM,
    3. Karavasilis L
    . Childhood sexual abuse and pubertal timing: Implications for long-term psychosocial adjustment. In Hayward C, editor, Gender Differences at Puberty. London, U.K.: Cambridge University Press; 2003. p. 187–216
  75. 75.
    1. Biswas B,
    2. Vaughn MG
    . Really troubled girls: Gender differences in risky sexual behavior and its correlates in a sample of juvenile offenders. Child Youth Serv Rev. 2011 Nov; 33(11):2386–91
  76. 76.
    1. Kelly PJ,
    2. Bair RM,
    3. Baillargeon J,
    4. German V
    . Risk behaviors and prevalence of chlamydia in a juvenile detention facility. Clin Pediatr (Phila). 2000 Sep; 39(9):521–7
  77. 77.
    1. Crosby R,
    2. Salazar LF,
    3. Diclemente RJ
    et al. Health risk factors among detained adolescent females. Am J Prev Med. 2004 Dec; 27(5):404–10
  78. 78.
    1. Keenan K,
    2. Hipwell A,
    3. Chung T
    et al. The Pittsburgh Girls Study: Overview and initial findings. J Clin Child Adolesc Psychol. 2010 Jun; 39(4):506–21
  79. 79.
    1. Lederman CS,
    2. Dakof GA,
    3. Larrea MA,
    4. Li H
    . Characteristics of adolescent females in juvenile detention. Int’l J L & Psychiatry. 2004 Jul-Aug; 27(4):321–37
  80. 80.
    1. Rizk R,
    2. Alderman E
    . Issues in gynecologic care for adolescent girls in the juvenile justice system. J Pediatr Adolesc Gynecol. 2012 Feb; 25(1):2–5
  81. 81.
    1. Acoca L,
    2. Dedel K
    . No place to hide: Understanding and meeting the needs of girls in the California juvenile justice system [Internet]; 1998 Jul. Available from: https://www.ojp.gov/ncjrs/virtual-library/abstracts/no-place-hide-understanding-and-meeting-needs-girls-california. Accessed April 28, 2023
  82. 82.
    1. Level LD,
    2. Chamberlain P
    . Association with delinquent peers: Intervention effects for youth in the juvenile justice system. J Abnorm Child Psychol. 2005 Jun; 33(3):339–47
  83. 83.
    1. Eme RF
    . Selective female affliction in the developmental disorders of childhood: A literature review. J Clin Child Psychol. 1992 Dec; 21(4):354–64
  84. 84.
    1. Lahey BJ,
    2. Moffitt TE,
    3. Caspi A
    1. Keenan K,
    2. Shaw DS
    . Starting at the beginning: Exploring the etiology of antisocial behaviour in the first years of life. In Lahey BJ, Moffitt TE, Caspi A, editors. Causes of Conduct Disorder and Juvenile Delinquency. New York, NY: Guildford; 2003. p. 153–81
  85. 85.
    1. Moffitt TE,
    2. Caspi A
    . Childhood predictors differentiate life-course persistent and adolescence-limited antisocial pathways among males and females. Dev Psychopathol. 2001 Spring; 13(2):355–75
  86. 86.
    1. Teplin LA,
    2. McClelland GM,
    3. Abram KM
    et al. Violent death in delinquent youth after detention [Internet]; 2015 Sep. Available from: https://www.ojp.gov/ncjrs/virtual-library/abstracts/violent-death-delinquent-youth-after-detention. Accessed April 30, 2023
  87. 87.
    U.S. Department of Justice, Office of Juvenile Justice and Delinquency Prevention. 2019 annual report [Internet]; 2019. Available from: https://www.ojjdp.ojp.gov/sites/g/files/xyckuh176/files/media/document/253179.pdf. Accessed April 28, 2023
  88. 88.
    1. Branson CE,
    2. Baetz CL,
    3. Horwitz SM,
    4. Hoagwood KE
    . Trauma-informed juvenile justice systems: A systematic review of definitions and core components. Psychol Trauma. 2017 Nov; 9(6):635–46
  89. 89.
    1. Ko SJ,
    2. Ford JD,
    3. Kassam-Adams N
    et al. Creating trauma-informed systems: Child welfare, education, first responders, health care, juvenile justice. Prof Psychol Res Pr. 2008 Aug; 39(4):396–404
  90. 90.
    1. Penn JV,
    2. Thomas C
    . Practice parameter for the assessment and treatment of youth in juvenile detention and correctional facilities. J Am Acad Child Adolesc Psychiatry. 2005 Oct; 44(10):1085–98
  91. 91.
    1. Frank RT
    . The hormonal causes of premenstrual tension. Arch NeurPsych. 1931 Nov; 26(5):1053–7
  92. 92.
    1. Yonkers KA,
    2. Simoni MK
    . Premenstrual disorders. Am J Obstet Gynecol. 2018 Jan; 218(1):68–74
  93. 93.
    1. Greene R,
    2. Dalton K
    . The premenstrual syndrome. Br Med J. 1953 May; 1:1007–14
  94. 94.
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Washington, DC: American Psychiatric Association, 2013
  95. 95.
    World Health Organization. International Statistical Classification of Diseases and Related Health Problems, Eleventh Edition. Geneva, Switzerland: World Health Organization; 2019
  96. 96.
    1. Gehlert S,
    2. Song IH,
    3. Chang C-H,
    4. Hartlage SA
    . The prevalence of premenstrual dysphoric disorder in a randomly selected group of urban and rural women. Psychol Med. 2009 Jan; 39(1):129–36
  97. 97.
    1. Cohen LS,
    2. Soares CN,
    3. Otto MW
    et al. Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard Study of Moods and Cycles. J Affect Disord. 2002 Jul; 70(2):125–32
  98. 98.
    1. Martinez PE,
    2. Rubinow DR,
    3. Nieman LK
    et al. 5α-reductase inhibition prevents the luteal phase increase in plasma allopregnanolone levels and mitigates symptoms in women with premenstrual dysphoric disorder. Neuropsychopharmacology. 2016 Mar; 41(4):1093–102
  99. 99.
    1. Hantsoo L,
    2. Epperson CN
    . Premenstrual dysphoric disorder: Epidemiology and treatment. Curr Psychiatry Rep. 2015 Nov; 17(11):87
  100. 100.
    1. Kim DR,
    2. Gyulai L,
    3. Freeman EW
    et al. Premenstrual dysphoric disorder and psychiatric co-morbidity. Arch Womens Ment Health. 2004 Feb; 7(1):37–47
  101. 101.
    1. Ducasse D,
    2. Jaussent I,
    3. Olié E
    et al. Personality traits of suicidality are associated with premenstrual syndrome and premenstrual dysphoric disorder in a suicidal women sample. PLoS ONE. 2016 Feb; 11(2):e0148653
  102. 102.
    1. Dalton K
    . Menstruation and acute psychiatric illnesses. Br Med J. 1959 Jan; 1:148–9
  103. 103.
    1. Dalton K
    . Menstruation and crime. Br Med J. 1961 Dec; 2(5269):1752–3
  104. 104.
    1. Dalton K
    . Cyclical criminal acts in premenstrual syndrome. Lancet. 1980 Nov; 2(8203):1070–1
  105. 105.
    1. Chait L
    . Premenstrual syndrome and our sisters in crime: A feminist dilemma. Women’s Rts L Rep. 1986; 9:267–93
  106. 106.
    1. Robinson GE
    . Legal implications of premenstrual syndrome: A Canadian perspective. CMAJ. 1986 Dec; 135(12):1340–1
  107. 107.
    1. Langer R
    . “That time of month:” Premenstrual dysphoric disorder in the criminal law—Another look. Int’l J Criminology & Soc. 2012; 1:29–44
  108. 108.
    1. Kaye NS
    . The Mary Harris PMS trial. J Clin Psychiatry. 1989 Aug; 50:308–9
  109. 109.
    1. Spiegel AD,
    2. Suskind PB
    . A paroxysmal insanity plea in an 1865 murder trial. J Leg Med. 1995; 16(4):585–606
  110. 110.
    1. Ginsburg BE,
    2. Carter BF
    1. Boorse C
    . Premenstrual syndrome and criminal responsibility. In: Ginsburg BE, Carter BF, editors. Premenstrual Syndrome. Boston MA: Springer; 1987. p. 81–124
  111. 111.
    1. D’Orbán PT
    . Baby stealing. Br Med J. 1972 Jun; 2:635–9
  112. 112.
    1. d’Orbán PT
    . Child stealing and pseudocyesis. Br J Psychiatry. 1982 Aug; 141:196–8
  113. 113.
    1. Rabun JB Jr.,
    2. Delaney TA,
    3. Rodriguez RD Jr.,
    4. Spring MP
    . Guidelines on preventing abduction of infants from the hospital. National Center for Missing and Exploited Children. J Healthc Prot Manage. 1992 Summer; 8:36–49
  114. 114.
    1. Burgess AW,
    2. Baker T,
    3. Nahirny C,
    4. Rabun JB Jr.
    Newborn kidnapping by cesarean section. J Forensic Sci. 2002 Jul; 47(4):827–30
  115. 115.
    1. Friedman SH
    1. Frierson RL
    . Feticide. In Friedman SH, Group for the Advancement of Psychiatry, editors. Family Murder: Pathologies of Love and Hate. Washington, DC: American Psychiatric Press; 2018. p. 39–52
  116. 116.
    1. Resnick PJ
    . Child murder by parents: a psychiatric review of filicide. American journal of psychiatry. 1969 Sep; 126(3):325–34
  117. 117.
    1. Friedman SH,
    2. Cavney J,
    3. Resnick PJ
    . Child murder by parents and evolutionary psychology. Psychiatr Clin North Am. 2012 Dec; 35(4):781–95
  118. 118.
    1. Friedman SH,
    2. Resnick PJ
    . Neonaticide: Phenomenology and considerations for prevention. Int’l J L & Psychiatry. 2009 Jan-Feb; 32(1):43–7
  119. 119.
    1. Spinelli MG
    . A systematic investigation of 16 cases of neonaticide. Am J Psychiatry. 2001 May; 158(5):811–3
  120. 120.
    1. Friedman SH,
    2. Horwitz SM,
    3. Resnick PJ
    . Child murder by mothers: A critical analysis of the current state of knowledge and a research agenda. Am J Psychiatry. 2005 Sep; 162(9):1578–87
  121. 121.
    1. Shelton JLE,
    2. Muirhead Y,
    3. Canning KE
    . Ambivalence toward mothers who kill: An examination of 45 U.S. cases of maternal neonaticide. Behav Sci & L. 2010 Nov-Dec; 28(6):812–31
  122. 122.
    1. Ramchandani A
    . Does Gail Ritchey belong in prison? Mother Jones [Internet]; 2022 Mar 24. Available from: https://www.motherjones.com/crime-justice/2022/03/gail-ritchey-neonaticide-trial-geauga-county. Accessed April 30, 2023
  123. 123.
    1. Friedman SH,
    2. Resnick PJ
    . Child murder by mothers: Patterns and prevention. World Psychiatry. 2007 Oct; 6:137–41
  124. 124.
    1. Friedman SH,
    2. Prakash C,
    3. Nagle-Yang S
    . Postpartum psychosis: Protecting mother and infant. Current Psychiatry. 2019 Apr; 18:12–21
  125. 125.
    1. Chandra PS,
    2. Venkatasubramanian G,
    3. Thomas T
    . Infanticidal ideas and infanticidal behavior in Indian women with severe postpartum psychiatric disorders. J Nerv Ment Dis. 2002 Jul; 190(7):457–61
  126. 126.
    1. Friedman SH,
    2. Friedman JB
    . Parents who kill their children. Pediatr Rev. 2010 Feb; 31(2):e10–6
  127. 127.
    1. Flynn SM,
    2. Shaw JJ,
    3. Abel KM
    . Filicide: Mental illness in those who kill their children. PLoS One. 2013 Apr; 8(4):e58981
  128. 128.
    1. Friedman SH,
    2. Resnick PJ
    . Child murder and mental illness in parents: Implications for psychiatrists. J Clin Psychiatry. 2011 May; 72:587–8
  129. 129.
    1. Laursen TM,
    2. Munk-Olsen T,
    3. Mortensen PB
    et al. Filicide in offspring of parents with severe psychiatric disorders: A population-based cohort study of child homicide. J Clin Psychiatry. 2011 May; 72(5):698–703
  130. 130.
    1. Friedman SH,
    2. Sorrentino RM,
    3. Stankowski JE
    et al. Psychiatrists’ knowledge about maternal filicidal thoughts. Compr Psychiatry. 2008 Jan-Feb; 49(1):106–10
  131. 131.
    1. Friedman SH,
    2. Hrouda DR,
    3. Holden CE
    et al. Filicide-suicide: Common factors in parents who kill their children and themselves. J Am Acad Psychiatry Law. 2005 Jan; 33(4):496–504
  132. 132.
    1. Jacobs D
    1. Nock MK,
    2. Marzuk PM
    . Murder-suicide: Phenomenology and clinical implications. In Jacobs D, editor. Harvard Medical School Guide to Suicide Assessment and Intervention. San Francisco, CA: Jossey-Bass; 1999. p. 188–209
  133. 133.
    1. Parnham G,
    2. Wong G
    1. Friedman SH,
    2. Riordan D,
    3. Short J
    . Writing the maternal filicide report: Pearls of wisdom for the expert witness. In Parnham G, Wong G, editors. Infanticide and Filicide: Foundations in Maternal Mental Health Forensics. Washington DC: American Psychiatric Association Press; 2020. p. 217–64
  134. 134.
    1. Friedman SH,
    2. Hrouda DR,
    3. Holden CE
    et al. Child murder committed by severely mentally ill mothers: An examination of mothers found not guilty by reason of insanity. J Forensic Sci. 2005 Nov; 50(6):1466-71
  135. 135.
    1. Monazzam N,
    2. Budd KM
    . Fact sheet: Incarcerated women and girls. The Sentencing Project [Internet]; 2023 Apr. Available from: https://www.sentencingproject.org/publications/incarcerated-women-and-girls/. Accessed April 11, 2021
  136. 136.
    1. Friedman SH,
    2. Kaempf A,
    3. Kauffman S
    . The realities of pregnancy and mothering while incarcerated. J Am Acad Psychiatry Law. 2020 Sep; 48(3):365–75
  137. 137.
    Health Services Advisory Group, prepared for the Centers for Medicare & Medicaid Services. Inpatient Psychiatric Facility Outcome and Process Measure Development and Maintenance Project Methodology Report: Screening for Pregnancy Measure; 2018
  138. 138.
    1. Sufrin C,
    2. Jones RK,
    3. Mosher WD,
    4. Beal L
    . Pregnancy prevalence and outcomes in U.S. jails. Obstet Gynecol. 2020 May; 135(5):1177–83
  139. 139.
    1. Goyal MK,
    2. Hersh AL,
    3. Badolato G
    et al. Underuse of pregnancy testing for women prescribed teratogenic medications in the emergency department. Acad Emerg Med. 2015 Feb; 22(2):192–6
  140. 140.
    1. Sufrin C,
    2. Beal L,
    3. Clarke J
    et al. Pregnancy outcomes in US prisons, 2016–2017. Am J Public Health. 2019 May; 109:799–805
  141. 141.
    2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019 Apr; 67:674–94
  142. 142.
    1. Kelsey CM,
    2. Medel N,
    3. Mullins C
    et al. An examination of care practices of pregnant women incarcerated in jail facilities in the United States. Matern Child Health J. 2017 Jun; 21(6):1260–6
  143. 143.
    National Commission on Correctional Health Care. Women’s health care in correctional settings: Position statement [Internet]; 2020. Available from: https://www.ncchc.org/position-statements/womens-health-care-in-correctional-settings-2020. Accessed April 12, 2021
  144. 144.
    1. du Toit E,
    2. Jordaan E,
    3. Niehaus D
    et al. Risk factors for unplanned pregnancy in women with mental illness living in a developing country. Arch Womens Ment Health. 2018 Jun; 21(3):323–31
  145. 145.
    1. Clarke JG,
    2. Hebert MR,
    3. Rosengard C
    et al. Reproductive health care and family planning needs among incarcerated women. Am J Public Health. 2006 May; 96:834–9
  146. 146.
    1. Kasdan D
    . Abortion access for incarcerated women: Are correctional health practices in conflict with constitutional standards. Perspect Sex Reprod Health. 2009 Mar; 41(1):59–62
  147. 147.
    1. Peart MS,
    2. Knittel AK
    . Contraception need and available services among incarcerated women in the United States: A systematic review. Contracept Reprod Med. 2020 Mar; 5:2
  148. 148.
    1. Sufrin CB,
    2. Creinin MD,
    3. Chang JC
    . Incarcerated women and abortion provision: A survey of correctional health providers. Perspect Sex Reprod Health. 2009 Mar; 41(1):6–11
  149. 149.
    Informed consent and shared decision making in obstetrics and gynecology: ACOG Committee Opinion No. 819. Obstet Gynecol. 2021 Feb; 137:e34–41
  150. 150.
    1. Friedman SH,
    2. Landess J,
    3. Ross N,
    4. Kaempf A
    . Evolving abortion law and forensic psychiatry. J Am Acad Psychiatry Law. 2022 Dec; 50(4):494–501
  151. 151.
    1. Acera Pozzi R,
    2. Yee LM,
    3. Brown K
    et al. Pregnancy in the severely mentally ill patient as an opportunity for global coordination of care. Am J Obstet Gynecol. 2014 Jan; 210(1):32–7
  152. 152.
    1. Sufrin CB,
    2. Tulsky JP,
    3. Goldenson J
    et al. Emergency contraception for newly arrested women: Evidence for an unrecognized public health opportunity. J Urban Health. 2010 Mar; 87(2):244–53
  153. 153.
    1. McLennan JD,
    2. Ganguli R
    . Family planning and parenthood needs of women with severe mental illness: Clinicians’ perspective. Community Ment Health J. 1999 Aug; 35(4):369–80
  154. 154.
    1. Kavanaugh ML,
    2. Jerman J
    . Contraceptive method use in the United States: Trends and characteristics between 2008, 2012 and 2014. Contraception. 2018 Jan; 97(1):14–21
  155. 155.
    Estelle v. Gamble, 429 U.S. 97 (1976)
  156. 156.
    The Rebecca Project for Human Rights/National Women’s Law Center. Mothers behind bars: A state-by-state report card analysis of federal policies on conditions of confinement for pregnant and parenting women and the effect on their children [Internet]; 2010 Oct. Available from: https://nwlc.org/wp-content/uploads/2015/08/mothersbehindbars2010.pdf. Accessed April 20, 2021
  157. 157.
    United States Government Accountability Office Report to Congressional Requestors. Pregnant women in DOJ custody: U.S. marshals service and bureau of prisons should better align policies with national guidelines [Internet]; 2021. Available from: https://www.gao.gov/assets/gao-21-147.pdf. Accessed April 20, 2021
  158. 158.
    1. Friedman SH,
    2. Hall RCW
    . Avoiding malpractice while treating depression in pregnant women: Consider the risks of untreated mental illness as well as the risks of antidepressant exposure. Current Psychiatry. 2021 Aug; 20:30–6
  159. 159.
    Treatment and management of mental health conditions during pregnancy and postpartum: ACOG Clinical Practice Guideline No. 5. Obstet Gynecol. 2023 Jun; 141(6):1262–88
  160. 160.
    1. Molenaar NM,
    2. Kamperman AM,
    3. Boyce P,
    4. Bergink V
    . Guidelines on treatment of perinatal depression with antidepressants: An international review. Aust N Z J Psychiatry. 2018 Apr; 52(4):320–7
  161. 161.
    1. Friedman SH,
    2. Moller-Olsen C,
    3. Prakash C,
    4. North A
    . Atypical antipsychotic use and outcomes in an urban maternal mental health service. Int J Psychiatry Med. 2016 Aug; 51(6):521–33
  162. 162.
    1. Sadowski A,
    2. Todorow M,
    3. Brojeni PY
    et al. Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: A cohort study. BMJ Open. 2013 Jul; 3(7):e003062
  163. 163.
    1. Testa A,
    2. Jackson DB
    . Incarceration exposure during pregnancy and infant health: Moderation by public assistance. 2020 Nov; J Pediatr. 226:251–7.e1
  164. 164.
    1. Knight M,
    2. Plugge E
    . The outcomes of pregnancy among imprisoned women: A systematic review. BJOG. 2005 Nov; 112(11):1467–74
  165. 165.
    1. Howard DL,
    2. Strobino D,
    3. Sherman SG,
    4. Crum RM
    . Maternal incarceration during pregnancy and infant birthweight. Matern Child Health J. 2011 May; 15:478–86
  166. 166.
    1. Hall RCW,
    2. Friedman SH,
    3. Jain A
    . Pregnant women and the use of corrections restraints and substance use commitment. J Am Acad Psychiatry Law. 2015 Sep; 43(3):359–68
  167. 167.
    1. Knox DK,
    2. Holloman GH Jr.
    Use and avoidance of seclusion and restraint: Consensus statement of the American Association for Emergency Psychiatry Project BETA seclusion and restraint workgroup. West J Emerg Med. 2012 Feb; 13(1):35–40
  168. 168.
    1. Wilson MP,
    2. Nordstrom K,
    3. Shah AA,
    4. Vilke GM
    . Psychiatric emergencies in pregnant women. Emerg Med Clin North Am. 2015 Nov; 33(4):841–51
  169. 169.
    1. Recupero PR,
    2. Price M,
    3. Garvey KA
    et al. Restraint and seclusion in psychiatric treatment settings: Regulation, case law, and risk management. J Am Acad Psychiatry Law. 2011; 39(4):465–76
  170. 170.
    National Resource Center on Justice-Involved Women. Best practices in the use of restraints with pregnant women and girls under correctional custody [Internet]; 2014. Available from: https://cjinvolvedwomen.org/resources/best-practices-in-the-use-of-restraints-with-pregnant-women-and-girls-under-correctional-custody. Accessed April 30, 2023
  171. 171.
    1. Anokye R,
    2. Acheampong E,
    3. Budu-Ainooson A
    et al. Prevalence of postpartum depression and interventions utilized for its management. Ann Gen Psychiatry. 2018 May; 17:18
  172. 172.
    1. Lindahl V,
    2. Pearson JL,
    3. Colpe L
    . Prevalence of suicidality during pregnancy and the postpartum. Arch Womens Ment Health. 2005 Jun; 8:77–87
  173. 173.
    1. Tosto V,
    2. Ceccobelli M,
    3. Lucarini E
    et al. Maternity blues: A narrative review. J Pers Med. 2023 Jan; 13(1):154
  174. 174.
    1. Ghaedrahmati M,
    2. Kazemi A,
    3. Kheirabadi G
    et al. Postpartum depression risk factors: A narrative review. J Edu Health Promot. 2017 Aug; 6(1):60
  175. 175.
    1. Friedman SH,
    2. Resnick PJ
    . Postpartum depression: An update. Womens Health (Lond). 2009 May; 5(3):287–95
  176. 176.
    1. Azorin J-M,
    2. Angst J,
    3. Gamma A
    et al. Identifying features of bipolarity in patients with first-episode postpartum depression: Findings from the international BRIDGE study. J Affect Disord. 2012 Feb; 136(3):710–5
  177. 177.
    1. Bergink V,
    2. Rasgon N,
    3. Wisner KL
    . Postpartum psychosis: Madness, mania, and melancholia in motherhood. Am J Psychiatry. 2016 Dec; 173(12):1179–88
  178. 178.
    1. Perry A,
    2. Gordon-Smith K,
    3. Jones L,
    4. Jones I
    . Phenomenology, epidemiology and aetiology of postpartum psychosis: A review. Brain Sci. 2021 Jan; 11(1):47
  179. 179.
    1. Kajstura A
    . Women’s mass incarceration: The whole pie 2019 [Internet]; 2019 Oct 29. Available from: https://www.prisonpolicy.org/reports/pie2019women.html. Accessed April 23, 2021
  180. 180.
    1. Clarke JG,
    2. Simon RE
    . Shackling and separation: Motherhood in prison. Virtual Mentor. 2013 Sep; 15:779–85
  181. 181.
    1. Johnston M,
    2. Landers S,
    3. Noble L
    et al. Breastfeeding and the use of human milk. Pediatrics. 2012 Mar; 129(3):e827–41
  182. 182.
    ACOG Committee opinion No. 756 summary: Optimizing support for breastfeeding as part of obstetric practice. Obstet Gynecol. 2018 Oct; 132:1086–8
  183. 183.
    1. Shlafer RJ,
    2. Davis L,
    3. Hindt LA
    et al. Intention and initiation of breastfeeding among women who are incarcerated. Nurs Womens Health. 2018 Feb; 22(1):64–78
  184. 184.
    ACOG Committee on Practice Bulletins–Obstetrics. ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation. Obstet Gynecol. 2008 Apr; 111:1001–20
  185. 185.
    1. Huang K,
    2. Atlas R,
    3. Parvez F
    . The significance of breastfeeding to incarcerated pregnant women: An exploratory study. Birth. 2012 Jun; 39(2):145–55
  186. 186.
    National Commission on Correctional Health Care. Breastfeeding in correctional settings [Internet]; 2018. Available from: https://www.ncchc.org/position-statements/breastfeeding-in-correctional-settings-2018/. Accessed April 30, 2023
  187. 187.
    1. Warner J
    . Infants in orange: An international model-based approach prison nurseries. Hastings Women's L J. 2015 Winter; 26(1):65
  188. 188.
    1. Byrne MW,
    2. Goshin LS,
    3. Joestl SS
    . Intergenerational transmission of attachment for infants raised in a prison nursery. Attach Human Dev. 2010 Jul; 12(4):375–93
  189. 189.
    1. Eddy JM,
    2. Poehlmann J
    1. Maruschak LM,
    2. Glaze LE,
    3. Mumola CJ
    . Incarcerated parents and their children: Findings from the Bureau of Justice Statistics. In: Eddy JM, Poehlmann J, editors. Children of Incarcerated Parents: A Handbook for Researchers and Practitioners. Washington, DC: Urban Institute Press; 2010. p. 33–54
  190. 190.
    1. Dallaire DH,
    2. Zeman JL,
    3. Thrash TM
    . Children’s experiences of maternal incarceration-specific risks: Predictions to psychological maladaptation. J Clin Child Adolesc Psychol. 2015; 44(1):109–22
  191. 191.
    1. Gilham JJM
    . A qualitative study of incarcerated mothers' perceptions of the impact of separation on their children. Soc Work Public Health. 2012; 27:89–103
  192. 192.
    United States Census Bureau. 65 and older population grows rapidly as Baby Boomers age [Internet]; 2020 Jun 25. Available from: https://www.census.gov/newsroom/press-releases/2020/65-older-population-grows.html. Accessed August 1, 2021
  193. 193.
    1. Colby SL,
    2. Ortman JM
    . Projections of the size and composition of the U.S. population: 2014 to 2060 [Internet]; 2015 Mar 3. Available from: https://www.census.gov/library/publications/2015/demo/p25-1143.html. Accessed April 30, 2023
  194. 194.
    1. Ash P,
    2. Frierson RL,
    3. Hatters-Friedman S
    1. Price M
    . Geriatric psychiatry. In Ash P, Frierson RL, Hatters-Friedman S, editors. Malpractice and Liability in Psychiatry. Cham, Switzerland: Springer Publishing; 2022. p. 207–16
  195. 195.
    1. Møller-Olsen C,
    2. Friedman SH,
    3. Prakash C,
    4. North A
    . Clinical characteristics of maternal mental health service users treated with mood stabilizing or antipsychotic medication. Asia Pac Psychiatry. 2018 Jun; 10(2):e12304
  196. 196.
    1. Aday R,
    2. Farney L
    . Malign neglect: Assessing older women’s health care experiences in prison. J Bioethical Inquiry. 2014 Sep; 11(3):359–72
  197. 197.
    1. Almeida OP,
    2. Marsh K,
    3. Flicker L
    et al. Depressive symptoms in midlife: The role of reproductive stage. Menopause. 2016 Jun; 23(6):669–75
  198. 198.
    1. Freeman EW,
    2. Sammel MD,
    3. Lin H,
    4. Nelson DB
    . Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry. 2006 Apr; 63(4):375–82
  199. 199.
    1. Friedman SH,
    2. Sajatovic M,
    3. Schuermeyer IN
    et al. Menopause-related quality of life in chronically mentally ill women. Int J Psychiatry Med. 2005; 35(3):259–71
  200. 200.
    1. Seeman MV
    . Psychosis in women: Consider midlife-medical and psychological triggers. Current Psychiatry. 2010 Feb; 9(2):64–8
  201. 201.
    1. Pudas S,
    2. Josefsson M,
    3. Rieckmann A,
    4. Nyberg L
    . Longitudinal evidence for increased functional response in frontal cortex for older adults with hippocampal atrophy and memory decline. Cereb Cortex. 2018 Mar; 28(3):936–48
  202. 202.
    1. Jacobs EG,
    2. Goldstein JM
    . The middle-aged brain: Biological sex and sex hormones shape memory circuitry. Curr Opin Behav Sci. 2018 Oct; 23:84–91
  203. 203.
    1. Jacobs EG,
    2. Weiss BK,
    3. Makris N
    et al. Impact of sex and menopausal status on episodic memory circuitry in early midlife. J Neurosci. 2016 Sept; 36(39):10163–73
  204. 204.
    1. Jacobs EG,
    2. Weiss B,
    3. Makris N
    et al. Reorganization of functional networks in verbal working memory circuitry in early midlife: The impact of sex and menopausal status. Cereb Cortex. 2017 May; 27(5):2857–70
  205. 205.
    1. Holzer JC,
    2. Kohn R,
    3. Ellison JM,
    4. Recupero PR
    1. Metzger ED,
    2. Holzer JC,
    3. Brendel RW
    . Forensic issues in geriatric psychiatry consult liaison service and the right to accept and refuse treatment. In Holzer JC, Kohn R, Ellison JM, Recupero PR, editors. Geriatric Forensic Psychiatry: Principles and Practice, New York, NY: Oxford University Press; 2018. p. 113–9
  206. 206.
    1. van der Feltz-Cornelis CM,
    2. Allen SF,
    3. van Eck van der Sluijs JF
    . Misdiagnosis of an underlying medical condition as conversion disorder/functional neurological disorder (CD/FND) still occurs. Gen Hosp Psychiatry. 2020 Jul-Aug; 65:43–6
  207. 207.
    1. Minton TD,
    2. Beatty LG,
    3. Zeng Z
    . Correctional population in the United States, 2019 [Internet]; 2021 Jul. Available from: https://bjs.ojp.gov/library/publications/correctional-populations-united-states-2019-statistical-tables. Accessed April 30, 2023
  208. 208.
    1. Fazel S,
    2. Baillargeon J
    . The health of prisoners. Lancet. 2011 Mar; 377(9769):956–65
  209. 209.
    1. Carson EA
    . Prisoners in 2014 [Internet]; 2015 Sep. Available from: bjs.ojp.gov/content/pub/pdf/p14.pdf. Accessed April 30, 2023
  210. 210.
    Human Rights Watch. Old behind bars: The aging prison population in the United States [Internet]; 2012 Jan 27. Available from: https://www.hrw.org/report/2012/01/28/old-behind-bars/aging-prison-population-united-states. Accessed April 30, 2023
  211. 211.
    1. Tamburello A,
    2. Metzner J,
    3. Fergusen E
    et al. The American Academy of Psychiatry and the Law practice resource for prescribing in corrections. J Am Acad Psychiatry Law. 2018 Jun; 46(2):242–3
  212. 212.
    1. Barry LC,
    2. Adams KB,
    3. Zaugg D,
    4. Noujaim D
    . Health-care needs of older women prisoners: Perspectives of the health-care workers who care for them. J Women Aging. 2020 Mar-Apr; 32(2):183–202
  213. 213.
    The Sentencing Project. The changing racial dynamics of women’s incarceration [Internet]; 2013 Oct. Available from: https://www.sentencingproject.org/webinar/the-changing-racial-dynamics-of-womens-incarceration. Accessed July 15, 2021
  214. 214.
    1. Williams BA,
    2. Lindquist K,
    3. Sudore RL
    et al. Being old and doing time: Functional impairment and adverse experiences of geriatric female prisoners. J Am Geriatr Soc. 2006 Apr; 54(4):702–7
  215. 215.
    1. Carson EA
    . Prisoners in 2019 [Internet]; 2020 Oct. Available from: https://bjs.ojp.gov/content/pub/pdf/p19.pdf. Accessed April 30, 2023
  216. 216.
    1. Stoliker BE,
    2. Verdun-Jones SN,
    3. Vaugham AD
    . The relationship between age and suicidal thoughts and attempted suicide among prisoners. Health & Just. 2020 Jun; 8(1):14
  217. 217.
    1. Friedman SH,
    2. Prakash C,
    3. Møller-Olson C
    . Psychiatric considerations in menopause. Current Psychiatry. 2018 Oct; 17(10):11–6
  218. 218.
    1. Maschi T,
    2. Kwak J,
    3. Ko E,
    4. Morrissey MB
    . Forget me not: Dementia in prison. Gerontologist. 2012 Aug; 52(4):441–51
  219. 219.
    1. Leigey ME,
    2. Hodge JP
    . Gray matters: Gender differences in the physical and mental health of older inmates. Just. 2012 Oct-Dec; 22(4):289–308
  220. 220.
    1. Nebel RA,
    2. Aggarwal NT,
    3. Barnes LL
    et al. Understanding the impact of sex and gender in Alzheimer’s disease: A call to action. Alzheimers Dement. 2018 Sep; 14(9):1171–83
  221. 221.
    1. Toro CA,
    2. Zhang L,
    3. Cao J,
    4. Cai D
    . Sex differences in Alzheimer’s disease: Understanding the molecular impact. Brain Res. 2019 Sep; 1719:194–207
  222. 222.
    1. Filon JR,
    2. Intorcia AJ,
    3. Sue LI
    et al. Gender differences in Alzheimer disease: Brain atrophy, histopathology burden, and cognition. J Neuropathol Exp Neurol. 2016 Aug; 75(8):748–54
  223. 223.
    1. Malpetti M,
    2. Ballarini T,
    3. Presotto L
    et al. Gender differences in healthy aging and Alzheimer’s dementia: A 18F-FDG-PET study of brain and cognitive reserve. Hum Brain Mapp. 2017 Aug; 38(8):4212–27
  224. 224.
    1. Laws KR,
    2. Irvine K,
    3. Gale TM
    . Sex differences in Alzheimer’s disease. Curr Opin Psychiatry. 2018 Mar; 31(2):133–9
  225. 225.
    1. Rochon PA,
    2. Gruneir A,
    3. Gill SS
    et al. Initial cholinesterase inhibitor therapy dose and serious events in older women and men. J Am Geriatr Soc. 2018 Sep; 66(9):1692–9
  226. 226.
    1. Das A,
    2. Minner R,
    3. Krain L,
    4. Spollen J
    . Delirium on clozapine: A tale of friend turned foe—A case report. Int J Psychiatry Med. 2021 Nov; 56(6):446–58
  227. 227.
    American Psychiatric Association. Position Statement on the Role of the Psychiatrist in Nursing Facilities. Arlington, VA: American Psychiatric Association; 2019
  228. 228.
    1. Holzer JC,
    2. Kohn R,
    3. Ellison JM,
    4. Recupero PR
    1. Fozdar MA,
    2. Holzer JC
    . Psychopharmacological agents, side effects, and black box warnings. In Holzer JC, Kohn R, Ellison JM, Recupero PR, editors. Geriatric Forensic Psychiatry: Principles and Practice. New York, NY: Oxford University Press; 2018. p. 121–7
  229. 229.
    1. Handtke V,
    2. Bretschneider W,
    3. Elger B,
    4. Wangmo T
    . Easily forgotten: Elderly female prisoners. J Aging Stud. 2015 Jan; 32:1–11
  230. 230.
    1. Reviere R,
    2. Young VD
    . Aging behind bars: Health care for older female inmates. J Women Aging. 2004; 16(1-2):55–69
  231. 231.
    1. Harrison PM,
    2. Beck AJ
    . Prisoners in 2002 [Internet]; 2003 Jul. Available from: https://bjs.ojp.gov/content/pub/pdf/p02.pdf. Accessed April 23, 2023
  232. 232.
    1. Fazel S,
    2. Yoon IA,
    3. Hayes AJ
    . Substance use disorders in prisoners: An updated systematic review and meta-regression analysis in recently incarcerated men and women. Addiction. 2017 Oct; 112(10):1725–39
  233. 233.
    1. Schuckit MA,
    2. Daeppen JB,
    3. Tipp JE
    et al. The clinical course of alcohol-related problems in alcohol dependent and nonalcohol dependent drinking women and men. J Stud Alcohol. 1998 Sep; 59(5):581–90
  234. 234.
    1. Friedman SH,
    2. Reed E
    . Treating psychosis in pregnant women: A measured approach. Current Psychiatry. 2021 Jul; 20:34–5
  235. 235.
    1. Cohen LS,
    2. Altshuler LL,
    3. Harlow BL
    et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA. 2006 Feb; 295(5):499–507
  236. 236.
    1. Viguera AC,
    2. Nonacs R,
    3. Cohen LS
    et al. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry. 2000 Feb; 157(2):179–84
  237. 237.
    1. Zarin DA,
    2. Pauker SG
    . Decision analysis as a basis for medical decision making: The tree of Hippocrates. J Med Philos. 1984 May; 9:181–213
  238. 238.
    1. Miller LJ
    . Ethical issues in perinatal mental health. Psychiatr Clin North Am. 2009 Jun; 32(2):259–70
  239. 239.
    1. Friedman SH,
    2. Hendrix T,
    3. Haberman J,
    4. Jain A
    . Judicial bypass of parental consent for abortion: Characteristics of pregnant minor “Jane Doe’s”. Journal Nerv Ment Dis. 2015 Jun; 203(6):401–5
  240. 240.
    1. Diav-Citrin O,
    2. Shectman S,
    3. Tahover E
    et al. Pregnancy outcome following in utero exposure to lithium: A prospective, comparative, observational study. Am J Psychiatry. 2014 Jul; 171(7):785–94
  241. 241.
    1. Macfarlane A,
    2. Greenhalgh T
    . Sodium valproate in pregnancy: What are the risks and should we use a shared decision-making approach? BMC Pregnancy Childb. 2018 Jun; 18(1):200
  242. 242.
    1. Miller LJ
    . Sexuality, reproduction, and family planning in women with schizophrenia. Schizophr Bull. 1997 Jan; 23(4):623–35
  243. 243.
    1. Louw K-A
    . Substance use in pregnancy: The medical challenge. Obstet Med. 2018 Jun; 11(2):54–66
  244. 244.
    1. Jarlenski M,
    2. Hogan C,
    3. Bogen DL
    et al. Characterization of U.S. state laws requiring health care provider reporting of perinatal substance use. Womens Health Issues. 2017 May-Jun; 27(3):264–70
  245. 245.
    1. Galmiche M,
    2. Déchelotte P,
    3. Lambert G,
    4. Tavolacci MP
    . Prevalence of eating disorders over the 2000–2018 period: A systematic literature review. Am J Clin Nutr. 2017 May-Jun; 109(5):1402–13
  246. 246.
    1. Chesney E,
    2. Goodwin GM,
    3. Fazel S
    . Risks of all-cause and suicide mortality in mental disorders: A meta-review. World Psychiatry. 2014 Jun; 13(2):153–60
  247. 247.
    1. Fichter MM,
    2. Quadflieg N
    . Mortality in eating disorders—Results of a large prospective clinical longitudinal study. Int J Eat Disord. 2016 Apr; 49(4):391–401
  248. 248.
    1. Robinson P.
    Severe and Enduring Eating Disorder (SEED): Management of Complex Presentations of Anorexia and Bulimia nervosa. Chichester, U.K.: Wiley-Blackwell Press; 2009
  249. 249.
    1. Robinson P
    . Severe and enduring eating disorders: Recognition and management. Adv Psychiatr Treat. 2014 Nov; 20(6):392–401
  250. 250.
    1. Hay P,
    2. Girosi F,
    3. Mond J
    . Prevalence and sociodemographic correlates of DSM-5 eating disorders in the Australian population. J Eat Disord. 2015 Apr; 3:19
  251. 251.
    1. Yager J
    . Managing patients with severe and enduring anorexia nervosa: When is enough, enough? J Nerv Ment Dis. 2020 Apr; 208(4):277–82
  252. 252.
    1. Fornari V,
    2. Dancyger I,
    3. Renz J
    et al. Eating disorders and pregnancy: Proposed treatment guidelines for obstetricians and gynecologists. OJOG. 2014 Feb; 4(2):90–4
  253. 253.
    1. Micali N,
    2. Treasure J,
    3. Simonoff E
    . Eating disorders symptoms in pregnancy: A longitudinal study of women with recent and past eating disorders and obesity. J Psychosom Res. 2007 Sep; 63(3):297–303
  254. 254.
    1. Bulik CM,
    2. Von Holle A,
    3. Siega-Riz AM
    et al. Birth outcomes in women with eating disorders in the Norwegian mother and child cohort study (MoBa). Int J Eat Disord. 2009 Jan; 42(1):9–18
  255. 255.
    1. Andersen AE,
    2. Ryan GL
    . Eating disorders in the obstetric and gynecologic patient population. Obstet Gynecol. 2009 Dec; 114(6):1353–67
  256. 256.
    1. Jacoangeli F,
    2. Masala S,
    3. Mezzasalma FS
    et al. Amenorrhea after weight recover in anorexia nervosa: Role of body composition and endocrine abnormalities. Eat Weight Disord. 2006 Mar; 11(1):e20–6
  257. 257.
    1. El Ghoch M,
    2. Calugi S,
    3. Chignola E
    et al. Body fat and menstrual resumption in adult females with anorexia nervosa: A 1-year longitudinal study. J Hum Nutr Diet. 2016 Oct; 29(5):662–6
  258. 258.
    1. Martínez-Olcina M,
    2. Rubio-Arias JA,
    3. Reche-García C
    et al. Eating disorders in pregnant and breastfeeding women: A systematic review. Medicina. 2020 Jul; 56(7):352
  259. 259.
    1. Claydon EA,
    2. Davidov DM,
    3. Zullig KJ
    et al. Waking up every day in a body that is not yours: A qualitative research inquiry into the intersection between eating disorders and pregnancy. BMC Pregnancy Childb. 2018 Nov; 18(1):63
  260. 260.
    1. Mazer-Poline C,
    2. Fornari V
    . Anorexia nervosa and pregnancy: Having a baby when you are dying to be thin—Case report and proposed treatment guidelines. Int J Eat Disord. 2009 May; 42(4):382–4
  261. 261.
    1. Bulik CM,
    2. Sullivan PF,
    3. Fear JL
    et al. Fertility and reproduction in women with anorexia nervosa: A controlled study. J Clin Psychiatry. 1999 Feb; 60(2):130–5
  262. 262.
    1. Kimmel MC,
    2. Ferguson EH,
    3. Zerwas S
    et al. Obstetric and gynecologic problems associated with eating disorders. Int J Eat Disord. 2016 Mar; 49(3):260–75
  263. 263.
    1. Koubaa S,
    2. Hällström T,
    3. Lindholm C,
    4. Lindén Hirschberg A
    . Pregnancy and neonatal outcomes in women with eating disorders. Obstet Gynecol. 2005 Feb; 105(2):255–60
  264. 264.
    1. Larsson G,
    2. Andersson-Ellström A
    . Experiences of pregnancy‐related body shape changes and of breast‐feeding in women with a history of eating disorders. Euro Eating Disorders Rev. 2003; 11(2):116–24
  265. 265.
    1. Westmoreland P,
    2. Johnson C,
    3. Stafford M
    et al. Involuntary treatment of patients with life-threatening anorexia nervosa. J Am Acad Psychiatry Law. 2017 Dec; 45(4):419–25
  266. 266.
    1. Bourion-Bedes S,
    2. Baumann C,
    3. Kermarrec S
    et al. Prognostic value of early therapeutic alliance in weight recovery: A prospective cohort of 108 adolescents with anorexia nervosa. J Adolesc Health. 2013 Mar; 52(3):344–50
  267. 267.
    1. McCormack L,
    2. Sly R
    . Distress and growth: The subjective “lived” experiences of being the child of a Vietnam veteran. Traumatology. 2013; 19(4):303–12
  268. 268.
    1. Galbally M,
    2. Himmerich H,
    3. Senaratne S
    et al. Management of anorexia nervosa in pregnancy: A systematic and state-of-the-art review. Lancet Psychiatry. 2022 May; 9(5):402–12
  269. 269.
    1. Gilbert R,
    2. Widom CS,
    3. Browne K
    et al. Burden and consequences of child maltreatment in high-income countries. Lancet. 2009 Jan; 373(9657):68–81
  270. 270.
    1. McEwan M,
    2. Friedman SH
    . Violence by parents against their children: Reporting of maltreatment suspicions, child protection, and risk in mental illness. Psychiatr Clin North Am. 2016 Dec; 39(4):691–700
  271. 271.
    1. Blanch AK,
    2. Nicholson J,
    3. Purcell J
    . Parents with severe mental illness and their children: The need for human services integration. J Ment Health Adm. 1994 Fall; 21(4):388–96
  272. 272.
    1. White CL,
    2. Nicholson J,
    3. Fisher WH,
    4. Geller JL
    . Mothers with severe mental illness caring for children. J Nerv Ment Dis. 1995 Jun; 183(6):398–403
  273. 273.
    1. Seeman MV
    . Intervention to prevent child custody loss in mothers with schizophrenia. Schizophr Res Treatment. 2012; 2012:796763
  274. 274.
    1. Hollingsworth LD
    . Child custody loss among women with persistent severe mental illness. Social Work Research. 2004 Dec; 28(4):199–209
  275. 275.
    1. Diaz-Caneja A,
    2. Johnson S
    . The views and experiences of severely mentally ill mothers. Soc Psychiatry Psychiatr Epidemiol. 2004 Jun; 39:472–82
  276. 276.
    Roe v. Wade, 410 U.S. 113 (1973)
  277. 277.
    Dobbs v. Jackson Women’s Health Organization, 597 U.S. 215 (2022)
  278. 278.
    1. Weinstock R,
    2. Connor D
    1. Friedman SH,
    2. Kaempf A,
    3. Landess J
    et al. Decisional capacity in terminating pregnancy. In Weinstock R, Connor D, editors. A Practical Guide to Forensic Psychiatric Ethics in the 21st Century: How to Resolve Ethics Dilemmas by Balancing Competing Neuropsychiatric and Legal Considerations. Washington, DC: APA Publishing; 2025
  279. 279.
    1. Ralph LJ,
    2. Chaiten L,
    3. Werth E
    et al. Reasons for and logistical burdens of judicial bypass for abortion in Illinois. J Adolesc Health. 2021 Jan; 68(1):71–8
  280. 280.
    1. Coleman-Minahan K,
    2. Stevenson AJ,
    3. Obront E,
    4. Hays S
    . Young women’s experiences obtaining judicial bypass for abortion in Texas. J Adolesc Health. 2019 Jan; 64(1):20–5
  281. 281.
    1. Yon Y,
    2. Mikton C,
    3. Gassoumis ZD,
    4. Wilber KH
    . The prevalence of self-reported elder abuse among older women in community settings: A systematic review and meta-analysis. TVA. 2019 Apr; 20(2):245–59
  282. 282.
    1. Frolik LA,
    2. Kaplan RL.
    Elder Law in a Nutshell, Seventh Edition. St. Paul, MN: West Academic Publishing; 2019
  283. 283.
    1. McNary AL
    . Managing your aging patient population. Innov Clin Neurosci. 2017 Apr; 14(3-4):41–4
  284. 284.
    1. Storey JE
    . Risk factors for elder abuse and neglect: A review of the literature. Aggress Violent Behav. 2020 Jan-Feb; 50:101339
  285. 285.
    1. Williams JL,
    2. Racette EH,
    3. Hernandez-Tejada MA,
    4. Acierno R
    . Prevalence of elder polyvictimization in the United States: Data from the National Elder Mistreatment Study. J Interpers Violence. 2020 Nov; 35(21-22):4517–32
  286. 286.
    1. Friedman SH
    . The ethics of treating depression in pregnancy. Journal of Primary Health Care. 2015 Mar 1; 7(1).

Site Navigation

  • Home
  • Current Issue
  • Ahead of Print
  • Archive
  • Information for Authors
  • About the Journal
  • Editorial Board
  • Feedback
  • Alerts

Other Resources

  • Academy Website
  • AAPL Meetings
  • AAPL Annual Review Course

Reviewers

  • Peer Reviewers

Other Publications

  • AAPL Practice Guidelines
  • AAPL Newsletter
  • AAPL Ethics Guidelines
  • AAPL Amicus Briefs
  • Landmark Cases

Customer Service

  • Cookie Policy
  • Reprints and Permissions
  • Order Physical Copy

Copyright © 2025 by The American Academy of Psychiatry and the Law